{"Title": ["Seattle Genetics Reaches Analyst Target Price", "Seattle Genetics To Present At Goldman Sachs Global Healthcare Conference; Webcast At 11:20 AM ET", "Seattle Genetics Reports Positive Results From HER2CLIMB Trial Of TUKYSA", "IBB, ILMN, SGEN, ALXN: ETF Inflow Alert", "Interesting SGEN Put And Call Options For July 17th", "XBI, MRNA, REGN, SGEN: ETF Inflow Alert", "Seattle: TUKYSA Approved In Switzerland To Treat HER2-positive Breast Cancer", "Health Care Sector Update for 05/01/2020: IMGN,SGEN,MOH,MGLN,ATHX", "Seattle Genetics Reaches Analyst Target Price", "Health Care Sector Update for 05/01/2020: SGEN,MOH,MGLN,ATHX", "Nasdaq 100 Movers: WDC, SGEN", "EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q1 Earnings Report", "Seattle Genetics Q1 20 Earnings Conference Call At 4:30 PM ET", "Interesting SGEN Put And Call Options For December 18th", "Is It Too Late to Buy Shares of Seattle Genetics?", "With FDA Approvals in Hand, These 2 Biotech Stocks Are on Wall Street\u2019s Radar", "Seattle Genetics Inc (SGEN) Q1 2020 Earnings Call Transcript", "Nasdaq 100 Movers: UAL, SGEN", "Seattle Genetics (SGEN) Merits Attention", "Seattle Genetics Reaches Analyst Target Price", "Immunomedics Halts Phase 3 Trial of Breast Cancer Drug Because of Compelling Efficacy", "Takeda Pharma Reports Positive CHMP Opinion For ADCETRIS - Quick Facts", "Interesting SGEN Put And Call Options For May 15th", "FXH, DXCM, ALNY, SGEN: Large Inflows Detected at ETF", "BUZZ-U.S. STOCKS ON THE MOVE-Co-Diagnostics, Xeris Pharma, Cyclacel Pharma", "RSI Alert: Seattle Genetics (SGEN) Now Oversold", "6 Quality Biotech Stocks on Sale Now", "Monday's ETF with Unusual Volume: FTLS", "Nasdaq 100 Movers: SGEN, JD", "Study Finds Breast Cancer Risk Can Rise by 50% for Women Who Drink a Cup of Milk Every Day", "FDA Delays Decision On HRTX Drug, KPTI On Watch, ADMP To Resubmit NDA In Q2", "Is Seattle Genetics Stock a Buy?", "How to Invest for Every Scenario", "Seattle Genetics, Astellas, and Merck Hit a Bladder Cancer Bullseye", "Nasdaq 100 Movers: MELI, TMUS", "Is Takeda Pharmaceutical Company Stock a Buy?", "Nasdaq 100 Movers: TCOM, TSLA", "Seattle Genetics Inc (SGEN) Q4 2019 Earnings Call Transcript", "Seattle Genetics Smashes Wall Street Estimates in Q4, but Its 2020 Guidance Disappoints", "3 Canadian Biotechs to Consider Buying Today", "Seattle Genetics' Experimental Breast Cancer Drug Receives Priority Review From the FDA", "Seattle Genetics Issues Outlook", "EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q4 Earnings Report", "Seattle Genetics Q4 19 Earnings Conference Call At 4:30 PM ET", "SGEN Crosses Above Average Analyst Target", "2 Top Healthcare Stocks to Buy Right Now", "Seattle Genetics : EMA Validates MAA For Tucatinib", "3 Top Biotech Stocks to Buy Right Now", "Seattle Genetics Reports Q4 Earnings Results", "Health Care Sector Update for 01/21/2020: ICCC,GNPX,AZN,SGEN,ADXS", "Health Care Sector Update for 01/21/2020: GNPX,AZN,SGEN,ADXS", "Seattle Genetics Achieves Milestone On EU Approval Of Roche's Polivy", "Are Biotech Stocks Due for a Correction in 2020?", "Seattle Genetics To Present At J.P. Morgan Conference; Webcast At 5:30 PM ET", "Seattle Genetics is Now Oversold (SGEN)", "Nasdaq 100 Movers: SGEN, TSLA", "Nasdaq 100 Movers: NTAP, TCOM", "These 3 Biotech Stocks Could Be Top Stocks in 2020", "SPDR S&P Biotech ETF Experiences Big Outflow", "Is Puma Biotechnology a Buy?", "Nasdaq 100 Movers: SGEN, GOOGL", "Nasdaq 100 Movers: SGEN, TCOM", "First Week of February 2020 Options Trading For Seattle Genetics", "2 Healthcare Stocks That Doubled in 2019 and Can Still Go Higher", "Why Seattle Genetics Stock Skyrocketed 102% in 2019", "A $20 Billion Sweet Spot in Biotech", "XBI, ICPT, SGEN, ALNY: Large Inflows Detected at ETF", "3 Blockbuster Cancer Drug Launches to Watch in 2020", "Health Care Sector Update for 12/23/2019: SGEN,NVS,ACB,ACB.TO,SRPT,ACOR", "USSG, IDNA: Big ETF Inflows", "Astellas : FDA Approves Padcev For Metastatic Urothelial Cancer", "SGEN Crosses Above Average Analyst Target", "2 Things That Will Propel Seattle Genetics\u2019 Stock Even Higher in 2020", "2 Breast Cancer Fighting Stocks to Invest In", "Seattle Genetics, Astellas, Merck To Evaluate Enfortumab Vedotin Plus KEYTRUDA", "FBT, QGEN, SGEN, ICPT: Large Outflows Detected at ETF", "Stuff Your IRA With the Best ETFs & Forget About \u2018Em", "Exelixis\u2019 Stock Regains Its Mojo", "Healthcare Stocks That Hit New Highs (ARWR, ELMD, SGEN...)", "Here's Why Seattle Genetics Stock Jumped 25.7% in October", "GILD's KTE-X19 To Face FDA, NTEC Drops As NVS Walks Away, KZIA On Watch", "Buy These 2 Stocks to Access China's Huge Healthcare Market", "Seattle Genetics Responds To Daiichi Sankyo's Declaratory Judgment Complaint", "Seattle Genetics Inc (SGEN) Q3 2019 Earnings Call Transcript", "EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q3 Earnings Report", "1 No-Brainer Pharmaceutical Stock to Buy", "5 Top Healthcare ETFs", "4 Stocks Battling Breast Cancer", "SGEN Crosses Above Average Analyst Target", "3 Cancer Treatment Stocks to Buy Right Now", "Is Seattle Genetics a Good Biotech Stock to Buy Now?", "Healthcare Stocks That Hit New Highs (SGEN, RCEL, REPH,...)", "Odonate On The Move With CONTESSA, FDA Snubs CLSD, It's A Yes For AZN, VRTX", "Why PetMed Express, Seattle Genetics, and Coty Jumped Today", "5 Top Stock Trades for Tuesday: PINS, BAC, TWTR", "Notable Monday Option Activity: FIT, SAFM, SGEN", "First Trust NYSE Arca Biotechnology Index Fund Experiences Big Outflow", "Here\u2019s Why Seattle Genetics Climbed Higher Today", "Seattle Genetics Announces Positive Topline Results From HER2CLIMB Trial", "Notable ETF Outflow Detected - XBI, SGEN, MDCO, ARWR", "2 Biotechs With Approaching Drug Approvals To Own Today", "Here's Why Puma Biotechnology Tumbled Today", "Here's Why Seattle Genetics Climbed 17.6% in September", "10 Great Biotech Stocks to Buy in Q4", "Monday's ETF with Unusual Volume: VOT", "Winners and Losers of Europe\u2019s Big Cancer Meeting", "SGEN Crosses Above Average Analyst Target", "Why Immunomedics Stock Is Sinking Today", "Here\u2019s Why Seattle Genetics Stock Jumped Higher Today", "XBI, MRTX, SGEN, REGN: Large Inflows Detected at ETF", "Health Care Sector Update for 09/27/2019: SGEN,PRPO,GOSS,VCNX", "Interesting SGEN Put And Call Options For January 2022", "How Amazon Is Shaking Up Telemedicine, Plus 1 Winner and 1 Loser Exiting ESMO", "Astellas Pharma: FDA Grants Priority Review For Enfortumab Vedotin - Quick Facts", "Seattle Genetics Enters Oversold Territory (SGEN)", "Seattle Genetics Breaks Below 200-Day Moving Average - Notable for SGEN", "Analysts Predict 11% Upside For The Holdings of JKH", "First Week of SGEN October 18th Options Trading", "3 'Perfect 10' Biotech Companies to Buy", "Health Care Sector Update for 07/24/2019: GILD,GHDX,EFII,EW,SGEN", "XLRN Pulls The Plug On FSHD Study, KPTI Well Funded, ACRS Up On Wart Trial Data", "Health Care Sector Update for 07/24/2019: ANTM, SGEN, TMO, JNJ, PFE, ABT, MRK, AMGN", "Seattle Genetics Hits Its Second Growth Phase", "Seattle Genetics (SGEN) Shares Cross Above 200 DMA", "Why Seattle Genetics, AVROBIO, and First Majestic Silver Jumped Today", "Health Care Sector Update for 07/17/2019: ADXS,SGEN,GHSI,IMRN", "Noteworthy Wednesday Option Activity: SGEN, NUS, QCOM", "Health Care Sector Update for 07/17/2019: SGEN,GHSI,IMRN", "Health Care Sector Update for 07/24/2019: GHDX,EFII,EW,SGEN", "Seattle Genetics Inc (SGEN) Q2 2019 Earnings Call Transcript", "Interesting SGEN Put And Call Options For July 19th", "SGEN Makes Notable Cross Below Critical Moving Average", "First Week of SGEN August 16th Options Trading", "Peek Under The Hood: FEX Has 10% Upside", "Seattle Genetics (SGEN) Shares Cross Above 200 DMA", "Notable Wednesday Option Activity: SGEN, ROKU, STZ", "Here's Why Seattle Genetics Rocketed Higher Today", "Health Care Sector Update for 04/26/2019: NVO,MDCO,RGEN,SGEN", "Health Care Sector Update for 04/26/2019: MDCO,RGEN,SGEN", "SEATTLE GENETICS INC (SGEN) Q1 2019 Earnings Call Transcript", "AMCA's Underlying Holdings Imply 10% Gain Potential", "SGEN Makes Notable Cross Below Critical Moving Average", "Health Care Sector Update for 04/11/2019: JNJ,ICPT,INNT,SGEN", "Health Care Sector Update for 04/11/2019: JNJ,ICPT,INNT,SGEN", "Seattle Genetics' \"Growth Is Tracking Well\"", "Health Care Sector Update for 04/26/2019: NVO,MDCO,RGEN,SGEN", "Health Care Sector Update for 04/05/2019: PGNX,LIVN,SGEN,AQB,XON", "Health Care Sector Update for 04/05/2019: LIVN,SGEN,AQB,XON", "Seattle Genetics, Astellas Report Positive Cancer Study Data", "Seattle Genetics (SGEN) Down 6.1% Since Last Earnings Report: Can It Rebound?", "Look Under The Hood: PBUS Has 10% Upside", "Health Care Sector Update for 04/11/2019: ICPT,INNT,SGEN", "Seattle Genetics' Adcetris Gets EC Nod for Label Expansion", "SGEN Crosses Below Key Moving Average Level", "Health Care Sector Update for 02/08/2019: APOP, SGEN, MBOT, JNJ, PFE, ABT, MRK, AMGN", "Why Goodyear Tire & Rubber, Henry Schein, and Seattle Genetics Slumped Today", "Seattle Genetics (SGEN) Q4 Loss Widens, Revenues Top Mark", "Health Care Sector Update for 02/08/2019: INGN,BIOC,QURE,SGEN", "Seattle Genetics Looks to Make Adcertis a Blockbuster; Investors Unimpressed", "SGEN April 18th Options Begin Trading", "Health Care Sector Update for 02/08/2019: BIOC,QURE,SGEN", "Seattle Genetics (SGEN) Q4 2018 Earnings Conference Call Transcript", "Earnings Reaction History: Seattle Genetics Inc., 60.0% Follow-Through Indicator, 5.0% Sensitive", "After-Hours Earnings Report for February 7, 2019 : FISV, RSG, FTV, VRSN, MSI, DXC, EXPE, MTD, IAC, SGEN, MHK, QRVO", "What's in the Cards for Glaxo (GSK) This Earnings Season?", "Regeneron (REGN) to Report Q4 Earnings: Is a Beat in Store?", "Seattle Genetics (SGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release", "Noteworthy Friday Option Activity: KTOS, ZAYO, SGEN", "Health Care Sector Update for 02/08/2019: BIOC,QURE,SGEN", "5 Biotech Stocks That Could Face M&A Next!", "Bullish Two Hundred Day Moving Average Cross - SGEN", "Seattle Genetics To Present At J.P. Morgan Conference; Webcast At 6:00 PM ET", "Seattle Genetics (SGEN) Looks Good: Stock Adds 5.6% in Session", "Seattle Genetics' Adcetris Gets Breakthrough Therapy Status", "Health Care Sector Update for 11/16/2018: AMED,ARNA, SGEN,HCM", "Interesting SGEN Put And Call Options For September 20th", "Add Up The Pieces: QUS Could Be Worth $87", "Seattle Genetics: \"Now the Hard Work Begins\"", "Interesting SGEN Put And Call Options For June 2019", "Seattle Genetics (SGEN) Q3 Loss In Line, Sales Top Mark", "Here's Why Seattle Genetics Plummeted Today", "Seattle Genetics Inc Breaks Below 200-Day Moving Average - Notable for SGEN", "Seattle Genetics Inc (SGEN) Q3 2018 Earnings Conference Call Transcript", "Health Care Sector Update for 11/16/2018: ARNA,UTHR,SGEN,HCM", "How The Parts Add Up: AMCA Headed For $32", "We Did The Math FXH Can Go To $89", "Seattle Genetics Reaches Analyst Target Price", "First Week of November 16th Options Trading For Seattle Genetics (SGEN)", "Seattle Genetics Reaches Analyst Target Price", "Bayer Plunges as Monsanto Fined $289M in Roundup Lawsuit", "Spectrum (SPPI) Earnings and Sales Miss Estimates in Q2", "Seattle Genetics is Now Oversold (SGEN)", "Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates", "Nektar (NKTR) Q2 Earnings In Line, Product Sales Down Y/Y", "Perrigo (PRGO) Beats on Q2 Earnings, Cuts View, Shares Down", "Sarepta (SRPT) Q2 Loss Narrows, Exondys 51 Drives Sales", "Horizon Pharma (HZNP) Q2 Earnings & Sales Beat, Shares Rise", "Mallinckrodt (MNK) Beats on Q2 Earnings and Sales, Ups View", "Catalyst (CPRX) Posts Narrower-Than-Expected Loss in Q2", "Endo (ENDP) Beats on Q2 Earnings & Sales, Raises Guidance", "VIVUS (VVUS) Q2 Loss Wider Than Expected, Revenues Up Y/Y", "Jazz Pharma's (JAZZ) Stock Down Despite Q2 Earnings Beat", "Arena Pharmaceuticals (ARNA) Q2 Loss Wider Than Expected", "Medicines Company (MDCO) Q2 Loss Narrows, Revenues Tank Y/Y", "Ophthotech (OPHT) Q2 Loss Narrows, Zimura Progress On Track", "Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down", "Seattle Genetics' Latest Approval Is the Best Yet", "AVEO Pharmaceuticals (AVEO) Q2 Loss In Line, Revenues Miss", "Health Care Sector Update for 07/27/2018: SGEN,NBRV,ABBV,TNXP", "First Week of SGEN March 2019 Options Trading", "4 Biotech Bets to Watch as Industry Rebounds in a Month", "SGEN Crosses Above Average Analyst Target", "10 Cancer-Fighting Health Care Stocks to Buy", "Why Is Seattle Genetics (SGEN) Up 13.3% Since Its Last Earnings Report?", "Add Up The Parts: PBUS Could Be Worth $30", "Seattle Genetics (SGEN) Q2 Loss Narrows, Sales Top Estimates", "Seattle Genetics Accelerates Revenue Growth, Earnings Not So Much", "Why Seattle Genetics Jumped Higher Today", "Seattle Genetics (SGEN) Q1 Earnings Lag Estimates, Sales Top", "Biotech Stock Roundup: PTGX Down, VRNA Up, AMGN's Repatha Gets Positive Opinion", "5 Biotech Stocks With Amazing Pipelines", "Cancer Space Roundup: NVS' Tasigna & SGEN's Adcetris Label Expansions in Focus", "Seattle Genetics' Adcetris Gets FDA Nod for Label Expansion", "Notable Monday Option Activity: SGEN, LMT, FNHC", "Seattle Genetics (SGEN) Up 8.4% Since Earnings Report: Can It Continue?", "SGEN Makes Bullish Cross Above Critical Moving Average", "Here's Why Pieris Pharmaceuticals Inc. Is Tanking", "Why Pieris Pharmaceuticals Inc. Is Soaring Today", "Health Care Sector Update for 02/09/2018: PACB,PIRS,SGEN,CTIC,TNDM", "Health Care Sector Update for 02/09/2018: PIRS,SGEN,CTIC,TNDM", "Seattle Genetics Is Growing Up Any Way It Can", "Is Celldex Therapeutics Stock About to Skyrocket?", "Implied VV Analyst Target Price: $137", "Earnings Reaction History: Seattle Genetics Inc., 66.7% Follow-Through Indicator, 3.4% Sensitive", "The Zacks Analyst Blog Highlights: Sanofi, Seattle Genetics, AbbVie, Celgene and Vertex", "Why Earnings Season Could Be Great for Seattle Genetics (SGEN)", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Biotech Roundup: Who's Popping On Drug, Merger, Earnings News?", "Midday Update: Wall Street Snaps Back as Boeing Keeps Dow Airborne", "Seattle Genetics (SGEN) Q4 Earnings & Revenues Top Estimates", "Implied VV Analyst Target Price: $137", "Close Update: Wall Street Recovers From Losses After Fed to Stem Two-Day Slide", "Here's Why Cascadian Therapeutics Jumped Up to 73.1% Today", "Seattle Genetics Adcetris Performs Well Despite Competition", "Seattle Genetics (SGEN) Shares Cross Above 200 DMA", "Seattle Genetics' Adcetris Gets EU Nod for Label Expansion", "Will 2018 Be Celldex Therapeutics, Inc.'s Best Year Yet?", "Wall Street in Upbeat Mood Ahead of FOMC Decision", "Biotech Stock Roundup: GWPH Submits Epidiolex in the EU, Sangamo Inks Deal with Pfizer", "Seattle Genetics' Adcetris sBLA Gets FDA Priority Review", "First Week of February 2018 Options Trading For Seattle Genetics (SGEN)", "Thursday's ETF Movers: FDN, FBT", "Why Seattle Genetics, Inc. Fell Today", "Immunomedics' Data Is Good News for Seattle Genetics, Too", "Why Immunomedics, Inc. Is Soaring Today", "Cancer Space Update: New Regulatory Status for 3 Major Drugs", "Biotech Stock Roundup: GWPH Submits Epidiolex in the EU, Sangamo Inks Deal with Pfizer", "Notable Monday Option Activity: SGEN, V, IBKR", "Seattle Genetics' Adcetris Gets FDA Nod for Label Expansion", "Noteworthy ETF Inflows: XBI, ALNY, PBYI, SGEN", "Noteworthy Wednesday Option Activity: SGEN, CYTK, WRD", "Seattle Genetics, Inc.: Double-Digit Revenue Growth, but the Best Is Yet to Come", "XBI, ALNY, PBYI, SGEN: ETF Inflow Alert", "Market-Moving News Is on Tap for Seattle Genetics", "Seattle Genetics (SGEN) Loss Narrows in Q3, Revenues Beat", "Is a Beat in Store for Agenus (AGEN) This Earnings Season?", "Should You Sell Seattle Genetics (SGEN) Before Earnings?", "Is a Beat in Store for Alexion (ALXN) This Earnings Season?", "XBI, ALNY, CLVS, SGEN: ETF Outflow Alert", "Cancer Space Update: Lung & Breast Cancer Studies in Focus", "Seattle Genetics Inks Clinical Collaborations for Cancer Drug", "IBD Rating Upgrades: Seattle Genetics Flashes Improved Price Strength", "Seattle Genetics Begins Phase II Study of Cancer Candidate", "Why Snap, Seattle Genetics, and Pretium Resources Jumped Today", "This Drugmaker Hit A 4-Month High On Collaboration With Dow's Merck", "Cancer Space Last Week Update: Pipeline Expansion in Focus", "Seattle Genetics Reaches Analyst Target Price", "Company News For Oct 3, 2017", "Seattle Genetics' Adcetris Gets Breakthrough Therapy Status", "SGEN Makes Bullish Cross Above Critical Moving Average", "Green Monday for Capital Markets Around the Globe", "Bristol-Myers (BMY) Opdivo Gets Approval for Liver Cancer", "Bristol-Myers' Opdivo Study Meets Early Success, Stock Up", "Pfizer's Acute Leukemia Drug Mylotarg Approved by the FDA", "Analysts Predict 12% Gains Ahead For FBT", "First Week of SGEN October 20th Options Trading", "Seattle Genetics' Adcetris Granted Priority Review by FDA", "Seattle Genetics (SGEN) in Focus: Stock Moves 7.9% Higher", "ImmunoGen, Inc. Earnings: What Goes Up, Must Come Down", "Seattle Genetics (SGEN) Q2 Loss Narrower than Expected", "The Zacks Analyst Blog Highlights: Merck, Celgene, Gilead Sciences, Seattle Genetics and Vanda Pharmaceuticals", "5 Drug Stocks Well Poised to Beat Q2 Earnings Estimates", "Pfizer's Mylotarg Recommended by FDA Advisory Committee", "Bristol-Myers' Opdivo Superior to Yervoy in Melanoma Study", "Roche's (RHHBY) Leukemia Drug Gets Prime Status in EU", "Seattle Genetics, Inc.: Expanded Sales on Their Way (FDA Willing)", "Seattle Genetics (SGEN) Reports Positive Data for Adcetris", "Mid-Day Update: U.S. Stocks Mixed as Oil Supply Worries Linger, Data Weakens", "Seattle Genetics Enters Oversold Territory (SGEN)", "Pre-Market Most Active for Jun 26, 2017 : AZN, VRX, MU, SGEN, P, QQQ, BAC, USLV, FB, CB, AAPL, TSM", "Why Frontier Communications, Seattle Genetics, and Arconic Slumped Today", "Why Shares of Seattle Genetics, Inc. Got Whacked Today", "Seattle Genetics (SGEN) Submits BLA to FDA for Cancer Drug", "FBT's Underlying Holdings Could Mean 11% Gain Potential", "Bristol-Myers Opdivo Positive in Phase II Study CheckMate-205", "Mid-Morning Market Update: Markets Open Higher; EQT To Buy Rice Energy For $6.7B", "Health Care Sector Update for 06/19/2017: PKI,NVDQ,SYK,SGEN", "Health Care Sector Update for 06/19/2017: CLVS,NVDQ,SYK,SGEN", "Baker Bros. Advisors Lp Buys Incyte Corp, AveXis Inc, La Jolla Pharmaceutical Co, Sells AbbVie ...", "Health Care Sector Update for 06/16/2017: SGEN,CLSN,IDXG", "Seattle Genetics Reports Updated Results on Cancer Drug", "Seattle Genetics Halts Phase III Study on Leukemia Drug", "Commit To Purchase Seattle Genetics At $50, Earn 10.6% Annualized Using Options", "Seattle Genetics, Inc. (SGEN) Leads 10 Notable Investor Filings", "ImmunoGen, Inc. Begins FORWARD I, Investors Wait", "The Head-Scratching Reason Immunomedics Rose by as Much as 12%", "Why Immunomedics, MercadoLibre, and Pearson Jumped Today", "Health Care Sector Update for 05/05/2017: RGLS,IMMU,SGEN,APHB", "Why Immunomedics, Inc. Rocketed Today", "Bristol-Myers Presents Data on Immuno-Oncology Drug Opdivo", "Seattle Genetics, Inc. Earnings: Solid Quarter, but Investors Wait", "Seattle Genetics (SGEN) Q1 Loss Widens, Sales Top Estimates", "Why Immunomedics, Inc. Got Hammered Today", "New Strong Sell Stocks for April 3rd", "Why Shares of Immunomedics Inc Are up an Astounding 89% in 2017", "Battle in the Boardroom: What's Next for Immunomedics", "Billionaires' Best Healthcare Stock Picks of 2017 (So Far)", "Health Care Sector Update for 05/05/2017: FLDM,IMMU,APHB", "Why Immunomedics, Inc. Jumped Higher Today", "Why Marathon Oil, Signet Jewelers, and Immunomedics Jumped Today", "Immunomedics (IMMU) Stock Soars After Deal with Seattle Genetics Is Halted", "Seattle Genetics (SGEN): FDA Lifts Hold on Trial of AML Drug", "Arch Coal, Seattle Genetics, Skyworks Solutions, Texas Instruments and Apple highlighted as Zacks Bull and Bear of the Day", "3 Biotech Long Shots: Boom Or Bust?", "First Week of April 21st Options Trading For Seattle Genetics", "Seattle Genetics (SGEN) Up 8.2% Since Earnings Report: Can It Continue?", "Will Seattle Genetics' Deal With Immunomedics Get Scuttled?", "Mid-Day Market Update: Infinera Surges On Earnings Beat; ChannelAdvisor Shares Plunge", "Health Care Sector Update for 02/10/2017: TCON,IMMU,SGEN,BSTG", "Seattle Genetics (SGEN) Loss Wider than Expected in Q4, Revenues Miss", "Health Care Sector Update for 02/10/2017: ONVO,IMMU,SGEN,BSTG", "After-Hours Earnings Report for February 9, 2017 : NVDA, TRI, ATVI, CERN, EXPE, MHK, AGU, WU, SGEN, VRSN, ZAYO, CSL", "3 Mid-Cap Biotech Stocks to Buy in February", "Seattle Genetics Earnings: Waiting on ECHELON", "5 Expensive Drugs That Could End Up in Trump's Crosshairs", "After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next", "Biotech Stocks: What to Watch in 2017", "Seattle Genetics' Acute Myeloid Leukemia Drug on FDA Hold", "Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold", "Why Seattle Genetics, Inc. Got Clobbered Today", "Health Care Sector Update for 12/27/2016: SGEN, IONS, JNJ, PFE, ABT, MRK, AMGN", "Lagoda Investment Management, L.P. Buys Texas Pacific Land Trust, Microsoft Corp, Coca-Cola Co, ...", "What Happened in the Stock Market Today", "Why Seattle Genetics, Inc. (SGEN), Endologix, Inc. (ELGX) and Amphastar Pharmaceuticals Inc (AMPH) Are 3 of Today\u2019s Worst Stocks", "Health Care Sector Update for 12/27/2016: SGEN,CAPN,ENGX", "Why Seattle Genetics Stock Surged Higher in November", "After Hours Most Active for Nov 30, 2016 : FDC, INFO, MSFT, BAC, SFUN, BMY, AAPL, SIRI, INTC, NRG, EPD, SGEN", "Friday's ETF with Unusual Volume: FNY", "Why These Biotechs Saw Double-Digit Gains Today", "Pre-Market Most Active for Dec 27, 2016 : SDRL, DNR, CHK, DB, SWN, VALE, CNAT, NVDA, SGEN, MU, SGYP, CLNE", "Health Care Sector Update for 11/08/2016: SGEN", "Insiders Buy Herbalife, Sell MasterCard", "4 Medical And Biotech Stocks to Watch", "5 Years After Adcetris Approval, Seattle Genetics, Inc. Still Focused on Pipeline", "Seattle Genetics (SGEN) Loss Narrower than Expected in Q3", "First Week of June 2017 Options Trading For Seattle Genetics (SGEN)", "Noteworthy ETF Outflows: FXH, SGEN, UTHR, LPNT", "FXH, WCG, SGEN, UTHR: Large Outflows Detected at ETF", "3 Biotechs That Could Be M&A Targets", "15,000 shares bought by Seattle Genetics Director", "Wednesday's ETF Movers: FBT, GDXJ", "We Did The Math BBH Can Go To $136", "ImmunoGen, Inc. Gets the FDA Green Light (for Its Trial Design)", "Seattle Genetics, Inc. Making the Most of It (and Then Some)", "Seattle Genetics' (SGEN) Loss Narrower than Expected in Q2", "SGEN Crosses Above Average Analyst Target", "What's in Store for these 5 Drug Stocks in Q2 Earnings?", "3 Stocks We're Buying Again", "3 Primary Ways Researchers Are Combatting Cancer", "5 Things Celldex Therapeutics, Inc. Wants You to Know", "AbbVie's ABT-414 Gets Rare Pediatric Disease Status in U.S.", "Seattle Genetics/Takeda Adectris' Label Expanded in the EU", "Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016", "Wednesday's ETF Movers: XBI, FXN", "Seattle Genetics Starts Trial on Acute Myeloid Leukemia Drug", "July 15th Options Now Available For Seattle Genetics (SGEN)", "3 Cancer-Fighting Stocks Making Waves in the Markets", "Seattle Genetics Breaks Above 200-Day Moving Average - Bullish for SGEN", "Commit To Buy Seattle Genetics At $25, Earn 8.5% Annualized Using Options", "Taking Inventory on Seattle Genetics, Inc. Earnings", "Seattle Genetics (SGEN) Posts Wider-than-Expected Q1 Loss", "Seattle Genetics Has Been Heating Up: Time to Buy?", "Seattle Genetics Starts Trial on Acute Myeloid Leukemia Drug", "Seattle Genetics (SGEN) Shares Cross Above 200 DMA", "5 Biotech Stocks to Bet on This Earnings Season", "Will Perrigo (PRGO) Surprise Earnings Estimates in Q1?", "Why Seattle Genetics, Inc. Stock Rose 10% in March", "SPDR S&P Biotech (ETF) (XBI) \u2013 The Best Biotech Investment Now", "Insiders Roundup: Theravance Biopharma, Western Gas, Upland Software", "Why Earnings Season Could Be Great for Seattle Genetics (SGEN)", "Seattle Genetics Initiates Phase I/II Study on SGN-CD33A", "Top Insider Trades of the Past Week", "SGEN: Insiders vs. Shorts", "Seattle Genetics' (SGEN) Q4 Loss Wider than Expected", "Health Care Sector Update for 02/10/2016: SGEN, TEAR, USNA", "Seattle Genetics, Inc. Grows Sales, Waits for Data", "Earnings Reaction History: Seattle Genetics Inc., 50.0% Follow-Through Indicator, 4.5% Sensitive", "Implied PXMG Analyst Target Price: $33", "Friday's ETF Movers: XOP, FBT", "Friday Sector Laggards: Biotechnology, Shipping Stocks", "Affimed & Merck Ink Deal for AFM13-Keytruda Combination", "Last Week's Best Healthcare ETF", "Seattle Genetics/Bristol-Myers Begin Adcetris-Opdivo Study", "Seattle Genetics Breaks Above 200-Day Moving Average - Bullish for SGEN", "Relative Strength Alert For Seattle Genetics", "Use Options For a Chance To Buy SGEN at a 23% Discount", "Seattle Genetics, Inc. Earnings: Extending the Runway", "Seattle Genetics' (SGEN) Loss Widens Y/Y, Outlook Upped", "Health Care Sector Update for 10/30/2015: GILD, SGEN", "SGEN Crosses Above Key Moving Average Level", "Health Care Sector Update for 10/19/2015: LJPC, GALT, SGEN", "SGEN Crosses Below Key Moving Average Level", "This Just In: Upgrades and Downgrades", "Use Options For a Chance To Buy SGEN at a 23% Discount", "Global Imbalances and the Chinese Economy - John Mauldin", "Seattle Genetics (SGEN) Catches Eye: Stock Moves Up 8.3%", "Health Care Sector Update for 09/14/2015: SGEN, TBPH, VRTX", "Pre-Market Most Active for Sep 11, 2015 : BHP, MRVL, ALU, NEP, AZN, XIV, TVIX, SGEN, SDRL, AAPL, BAC, FB", "Health Care Sector Update for 09/11/2015: MED, PFE, SGEN", "Interesting SGEN Put And Call Options For November 20th", "Here's Why the Baker Bros. Are Gobbling up This Emerging Cancer Company", "Seattle Genetics' Adcetris Label Expanded in the U.S.", "Health Care Sector Update for 08/18/2015: SGEN,OMER,AVEO", "Still Profitless in Seattle Genetics", "Seattle Genetics (SGEN) Loss Widens in Q2, Ups 2015 View - Analyst Blog", "First Week of SGEN March 2016 Options Trading", "Interesting SGEN Put And Call Options For August 21st", "Health Care Sector Update for 09/10/2015: SGEN, CYTX, LJPC", "Seattle Genetics-Unum Therapeutics Tie Up for Cancer Drugs - Analyst Blog", "Seattle Genetics Larger Than S&P 500 Component Tenet Healthcare", "First Week of July 17th Options Trading For Seattle Genetics (SGEN)", "Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape", "Seattle Genetics director buys more than 1 million shares", "Seattle Genetics Posts Narrower-than-Expected Loss in Q1 - Analyst Blog", "Seattle Genetics, Inc. Posts Solid First-Quarter Revenue, Raises Expense Guidance", "The Zacks Analyst Blog Highlights: Regeneron, Vertex, Celgene, Seattle Genetics and SAGE Therapeutics - Press Releases", "Seattle Genetics' Adcetris Under Review for New Indication - Analyst Blog", "Notable Two Hundred Day Moving Average Cross - SGEN", "SGEN Crosses Below Key Moving Average Level", "Seattle Genetics Larger Than S&P 500 Component Noble", "Seattle Genetics (SGEN) Shares Cross Above 200 DMA", "Seattle Genetics (SGEN) Filed Supplemental BLA for Adcetris - Analyst Blog", "Thursday's ETF Movers: PBE, ICF", "First Week of December 18th Options Trading For Seattle Genetics", "Ceiling seen for Seattle Genetics", "Seattle Genetics Posts Narrower-than-Expected Loss in Q4 - Analyst Blog", "Seattle Genetics, Inc. Exceeds Expecations", "Which Biotech Stock Should Pfizer, Inc. Buy?", "First Week of SGEN September 18th Options Trading", "Commit To Buy Seattle Genetics At $25, Earn 8.5% Annualized Using Options", "Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog", "Seattle Genetics' SEA-CD40 Enters Phase I for Solid Tumors - Analyst Blog", "Why Seattle Genetics, Inc. Stock Dove 12% in December", "New Biotech ETF From ALPS", "Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog", "Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day", "Dow 30 Stock Roundup: Chevron Acquires New Zealand Exploration Rights, Merck Announces Positive Keytruda Study Results - Analyst Blog", "Bristol-Myers Posts Positive Opdivo Hodgkin Lymphoma Data - Analyst Blog", "Merck's New Oncology Product Positive in Early Study - Analyst Blog", "Seattle Genetics, Bristol-Myers to Study Adcetris-Opdivo - Analyst Blog", "Seattle Genetics Inc. (SGEN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report", "Why the Earnings Streak Will Continue for Seattle Genetics (SGEN) - Tale of the Tape", "Friday's ETF Movers: GDXJ, BBH", "3 Biotech Stocks to Watch in November", "Seattle Genetics Gains on Narrower-than-Expected Q3 Loss - Analyst Blog", "Seattle Genetics, Inc. Posts Record Adcetris Sales", "Earnings Reaction History: Seattle Genetics Inc., 25.0% Follow-Through Indicator, 5.9% Sensitive", "Seattle Genetics Larger Than S&P 500 Component Nabors Industries", "Seattle Genetics-Takeda Reveal Impressive Adcetris Data - Analyst Blog", "Sector Update: Health-Care Shares Sink in Pre-Market Trade", "Sector Update: Health Care", "Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog", "Interesting SGEN Put And Call Options For November 22nd", "Merck KGaA Teams Up with Sutro for ADCs Targeting Cancer - Analyst Blog", "Seattle Genetics (SGEN) Shares Cross Below 200 DMA", "First Week of June 2015 Options Trading For Seattle Genetics (SGEN)", "Seattle Genetics-Takeda Reveal Impressive Adcetris Data - Analyst Blog", "Seattle Genetics (SGEN) Shares Cross Above 200 DMA", "AbbVie's ABT-414 Receives Orphan Drug Status in U.S. and EU - Analyst Blog", "Seattle Genetics Up on Narrower-than-Expected Q2 Loss - Analyst Blog", "Why the Earnings Streak Will Continue for Seattle Genetics (SGEN) - Tale of the Tape", "Merck KGaA-Mersana Therapeutics Strike a Deal on ADCs - Analyst Blog", "Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog", "First Week of SGEN October 18th Options Trading", "Seattle Genetics Larger Than S&P 500 Component Patterson Companies", "Interesting SGEN Put And Call Options For July 19th", "First Week of SGEN December 20th Options Trading", "Seattle Genetics Earns Milestone Payment - Analyst Blog", "SGEN Crosses Below Key Moving Average Level", "Interesting SGEN Put And Call Options For May 17th", "Can the Rally in Seattle Genetics (SGEN) Shares Continue? - Tale of the Tape", "First Week of SGEN April 19th Options Trading", "Earnings Reaction History: Seattle Genetics Inc., 12.5% Follow-Through Indicator, 4.5% Sensitive", "After-Hours Earnings Report for February 11, 2014 : DVA, TRIP, WU, TRMB, WSH, FRT, ACGL, PKG, FOSL, SGEN, EGN, HCC", "Japanese Approval for SGEN/Takeda's Adcetris - Analyst Blog", "Seattle Gentics-AbbVie Deal Expanded - Analyst Blog", "Stocks: Insiders Buy at Seattle Genetics, Opko Health, and Ion Geophysical", "Seattle Genetics director buys $16 million in shares", "Seattle Genetics Presents Data on Adcetris - Analyst Blog", "Bayer Eyeing Norwegian Oncology Firm - Analyst Blog", "Bayer in Oncology Deals - Analyst Blog", "Vertex Progresses with Kalydeco - Analyst Blog", "Intellipharmaceutics Reports Loss - Analyst Blog", "Bayer Inks Oncology Deal - Analyst Blog", "Bayer, Seattle Genetics Join Forces - Analyst Blog", "New Data on SGEN's Adcetris - Analyst Blog", "Insiders Buy Shares at Dollar General and Seattle Genetics; Rosetta Stone Sees a Sale", "SGEN Starts Adcetris Phase I/II Study - Analyst Blog", "Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker Buys ACADIA", "SGEN's Adcetris under FDA Review - Analyst Blog", "Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog", "Pharmacyclics Inc. (PCYC): Today's Most Compelling Stock Buy", "Polycyclics Inc. (PCYC): Today's Most Compelling Stock Pick", "Astellas, Ambrx Tie-Up on ADC - Analyst Blog", "Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs", "SGEN Seeks Adcetris Label Expansion - Analyst Blog", "SGEN Narrows Loss, Sales Rise - Analyst Blog", "After-Hours Earnings Report for February 12, 2013 : FTI, RAX, WU, FRT, WSH, DDR, CLF, ACC, HCC, GWR, SGEN, SKT", "Canada Approves Seattle Genetics' Adcetris - Analyst Blog", "Data From SGEN on Cancer Candidate - Analyst Blog", "SGEN/Takeda's Adcetris Progresses - Analyst Blog", "This Stock Could be Perfect for the \"Dividend Decade\"", "Takeda Files Adcetris in Japan - Analyst Blog", "WEEKLY CFO SELLS HIGHLIGHT: SBAC, XOXO, MTH, FICO, SGEN, OAS", "Seattle Genetics draws income trade", "Weekly CFO Sells Highlight: SWKS, P, SGEN, RT", "Biotech Ideas: Top Biotech Stocks with Bullish Institutional Trends", "5 Insider Stock Picks that Predictive Analysts Expect to Outperform", "Bullish Outlook: 10 Stocks Near Highs, Boosted by Insider Buying", "Welcome to a New Bear Market: Now What?", "Weekly CFO Sells Highlight: SGEN, PFIE, MAR, ESRX, LIOX, RGEN", "WEEKLY CFO SELLS HIGHLIGHT: SBAC, XOXO, MTH, FICO, SGEN, OAS", "Seattle Genetics draws income trade", "Stocks Mixed as Investors Await Fed Meeting Minutes; Commodities Higher", "Mid-Day Update: Equities Mixed While Commodities Sit Higher; Investors Focus on Fed", "Narrowing Down the List of Biotech ETFs to 2 We'd Recommend", "Stocks Lower as Investors Seek Clear Economic Indicators, Weigh Fed Chairman Comments", "Mid-Day Update: Stocks Modestly Lower as Investors Seek Clear Direction Following Fed Chief's Weekend Interview", "Investing 101: Short Squeeze Ideas with Insider Buying", "13 Biotechs to Watch for at Hematology Conference", "Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer"], "Elapsed Time": ["4 DAYS AGO", "4 DAYS AGO", "MAY 29, 2020", "MAY 26, 2020", "MAY 15, 2020", "MAY 13, 2020", "MAY 12, 2020", "MAY 1, 2020", "4 DAYS AGO", "MAY 1, 2020", "MAY 1, 2020", "APR 30, 2020", "APR 30, 2020", "APR 23, 2020", "APR 23, 2020", "APR 21, 2020", "MAY 1, 2020", "APR 16, 2020", "APR 13, 2020", "APR 7, 2020", "APR 6, 2020", "MAR 31, 2020", "MAR 27, 2020", "MAR 25, 2020", "APR 20, 2020", "MAR 13, 2020", "MAR 6, 2020", "MAR 2, 2020", "MAR 2, 2020", "FEB 25, 2020", "FEB 19, 2020", "FEB 17, 2020", "MAR 22, 2020", "FEB 11, 2020", "FEB 11, 2020", "FEB 11, 2020", "FEB 10, 2020", "FEB 7, 2020", "FEB 7, 2020", "FEB 7, 2020", "FEB 13, 2020", "FEB 6, 2020", "FEB 6, 2020", "FEB 6, 2020", "FEB 6, 2020", "FEB 4, 2020", "JAN 31, 2020", "JAN 30, 2020", "FEB 6, 2020", "JAN 21, 2020", "JAN 21, 2020", "JAN 21, 2020", "JAN 15, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 28, 2020", "JAN 11, 2020", "JAN 8, 2020", "JAN 8, 2020", "JAN 6, 2020", "JAN 2, 2020", "DEC 30, 2019", "DEC 30, 2019", "JAN 12, 2020", "DEC 28, 2019", "DEC 27, 2019", "DEC 24, 2019", "DEC 23, 2019", "DEC 23, 2019", "DEC 18, 2019", "DEC 16, 2019", "DEC 29, 2019", "DEC 6, 2019", "DEC 2, 2019", "NOV 25, 2019", "NOV 18, 2019", "NOV 18, 2019", "NOV 14, 2019", "NOV 7, 2019", "DEC 11, 2019", "NOV 6, 2019", "NOV 5, 2019", "OCT 30, 2019", "OCT 29, 2019", "OCT 29, 2019", "OCT 26, 2019", "OCT 26, 2019", "NOV 7, 2019", "OCT 23, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 21, 2019", "OCT 21, 2019", "OCT 21, 2019", "OCT 24, 2019", "OCT 21, 2019", "OCT 21, 2019", "OCT 16, 2019", "OCT 13, 2019", "OCT 8, 2019", "OCT 7, 2019", "OCT 7, 2019", "OCT 21, 2019", "OCT 2, 2019", "OCT 1, 2019", "SEP 30, 2019", "SEP 30, 2019", "SEP 30, 2019", "SEP 27, 2019", "SEP 18, 2019", "OCT 4, 2019", "SEP 16, 2019", "SEP 10, 2019", "SEP 9, 2019", "AUG 29, 2019", "AUG 20, 2019", "JUL 25, 2019", "JUL 24, 2019", "SEP 17, 2019", "JUL 24, 2019", "JUL 18, 2019", "JUL 17, 2019", "JUL 17, 2019", "JUL 17, 2019", "JUL 17, 2019", "JUL 17, 2019", "JUL 24, 2019", "JUL 17, 2019", "JUL 1, 2019", "JUN 26, 2019", "JUN 26, 2019", "JUN 24, 2019", "MAY 24, 2019", "MAY 8, 2019", "JUL 17, 2019", "APR 26, 2019", "APR 26, 2019", "APR 26, 2019", "APR 22, 2019", "APR 18, 2019", "APR 11, 2019", "APR 11, 2019", "APR 30, 2019", "APR 26, 2019", "APR 5, 2019", "APR 5, 2019", "MAR 29, 2019", "MAR 9, 2019", "MAR 7, 2019", "APR 11, 2019", "FEB 12, 2019", "FEB 8, 2019", "FEB 8, 2019", "FEB 8, 2019", "FEB 8, 2019", "FEB 8, 2019", "FEB 8, 2019", "FEB 12, 2019", "FEB 8, 2019", "FEB 8, 2019", "FEB 7, 2019", "FEB 7, 2019", "FEB 4, 2019", "FEB 4, 2019", "JAN 31, 2019", "FEB 8, 2019", "FEB 8, 2019", "JAN 10, 2019", "JAN 8, 2019", "JAN 7, 2019", "NOV 19, 2018", "NOV 16, 2018", "NOV 16, 2018", "JAN 24, 2019", "JAN 24, 2019", "OCT 30, 2018", "OCT 29, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 26, 2018", "NOV 16, 2018", "NOV 9, 2018", "OCT 9, 2018", "OCT 2, 2018", "SEP 26, 2018", "AUG 20, 2018", "AUG 14, 2018", "AUG 10, 2018", "OCT 24, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 9, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 7, 2018", "AUG 2, 2018", "AUG 2, 2018", "AUG 1, 2018", "JUL 31, 2018", "AUG 8, 2018", "JUL 27, 2018", "JUL 25, 2018", "JUL 20, 2018", "JUL 20, 2018", "JUL 20, 2018", "MAY 28, 2018", "MAY 18, 2018", "JUL 27, 2018", "MAY 2, 2018", "APR 27, 2018", "APR 27, 2018", "MAR 28, 2018", "MAR 27, 2018", "MAR 23, 2018", "MAR 21, 2018", "MAY 14, 2018", "MAR 8, 2018", "FEB 27, 2018", "FEB 14, 2018", "FEB 9, 2018", "FEB 9, 2018", "FEB 9, 2018", "FEB 8, 2018", "MAR 13, 2018", "FEB 7, 2018", "FEB 6, 2018", "FEB 5, 2018", "FEB 5, 2018", "FEB 3, 2018", "FEB 1, 2018", "JAN 31, 2018", "FEB 7, 2018", "JAN 31, 2018", "JAN 31, 2018", "JAN 31, 2018", "JAN 26, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 16, 2018", "JAN 31, 2018", "JAN 4, 2018", "JAN 3, 2018", "DEC 20, 2017", "DEC 14, 2017", "DEC 11, 2017", "DEC 8, 2017", "DEC 6, 2017", "JAN 5, 2018", "JAN 4, 2018", "NOV 27, 2017", "NOV 13, 2017", "NOV 7, 2017", "NOV 1, 2017", "NOV 1, 2017", "OCT 31, 2017", "DEC 4, 2017", "OCT 27, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 24, 2017", "OCT 23, 2017", "OCT 13, 2017", "OCT 12, 2017", "OCT 30, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 9, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 11, 2017", "OCT 2, 2017", "SEP 25, 2017", "SEP 8, 2017", "SEP 4, 2017", "AUG 31, 2017", "AUG 22, 2017", "AUG 17, 2017", "OCT 3, 2017", "JUL 31, 2017", "JUL 28, 2017", "JUL 14, 2017", "JUL 13, 2017", "JUL 12, 2017", "JUL 6, 2017", "JUN 30, 2017", "JUL 31, 2017", "JUN 27, 2017", "JUN 26, 2017", "JUN 26, 2017", "JUN 26, 2017", "JUN 26, 2017", "JUN 26, 2017", "JUN 21, 2017", "JUN 28, 2017", "JUN 19, 2017", "JUN 19, 2017", "JUN 19, 2017", "JUN 19, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 6, 2017", "JUN 20, 2017", "MAY 26, 2017", "MAY 18, 2017", "MAY 10, 2017", "MAY 8, 2017", "MAY 5, 2017", "MAY 5, 2017", "MAY 5, 2017", "JUN 5, 2017", "MAY 1, 2017", "APR 28, 2017", "APR 21, 2017", "APR 3, 2017", "MAR 28, 2017", "MAR 28, 2017", "MAR 21, 2017", "MAY 5, 2017", "MAR 9, 2017", "MAR 9, 2017", "MAR 9, 2017", "MAR 8, 2017", "FEB 27, 2017", "FEB 24, 2017", "FEB 22, 2017", "MAR 14, 2017", "FEB 12, 2017", "FEB 10, 2017", "FEB 10, 2017", "FEB 10, 2017", "FEB 10, 2017", "FEB 9, 2017", "JAN 29, 2017", "FEB 13, 2017", "JAN 18, 2017", "JAN 10, 2017", "DEC 29, 2016", "DEC 28, 2016", "DEC 28, 2016", "DEC 27, 2016", "DEC 27, 2016", "JAN 24, 2017", "DEC 27, 2016", "DEC 27, 2016", "DEC 27, 2016", "DEC 9, 2016", "NOV 30, 2016", "NOV 18, 2016", "NOV 9, 2016", "DEC 27, 2016", "NOV 8, 2016", "NOV 5, 2016", "NOV 2, 2016", "OCT 31, 2016", "OCT 28, 2016", "OCT 26, 2016", "OCT 19, 2016", "NOV 8, 2016", "SEP 24, 2016", "SEP 9, 2016", "SEP 7, 2016", "AUG 26, 2016", "AUG 9, 2016", "JUL 29, 2016", "JUL 27, 2016", "OCT 11, 2016", "JUL 25, 2016", "JUL 21, 2016", "JUL 16, 2016", "JUL 13, 2016", "JUL 12, 2016", "JUL 7, 2016", "JUN 30, 2016", "JUL 27, 2016", "MAY 26, 2016", "MAY 23, 2016", "MAY 20, 2016", "MAY 19, 2016", "MAY 6, 2016", "MAY 4, 2016", "APR 29, 2016", "JUN 10, 2016", "APR 27, 2016", "APR 25, 2016", "APR 25, 2016", "APR 15, 2016", "APR 12, 2016", "MAR 24, 2016", "MAR 19, 2016", "APR 27, 2016", "FEB 23, 2016", "FEB 20, 2016", "FEB 18, 2016", "FEB 10, 2016", "FEB 10, 2016", "FEB 10, 2016", "FEB 9, 2016", "MAR 11, 2016", "JAN 29, 2016", "JAN 29, 2016", "JAN 27, 2016", "JAN 2, 2016", "DEC 24, 2015", "DEC 16, 2015", "FEB 8, 2016", "NOV 10, 2015", "NOV 3, 2015", "OCT 30, 2015", "OCT 30, 2015", "OCT 23, 2015", "OCT 19, 2015", "NOV 24, 2015", "NOV 18, 2015", "NOV 10, 2015", "SEP 18, 2015", "SEP 14, 2015", "SEP 14, 2015", "SEP 11, 2015", "SEP 11, 2015", "SEP 25, 2015", "SEP 5, 2015", "AUG 18, 2015", "AUG 18, 2015", "JUL 31, 2015", "JUL 31, 2015", "JUL 21, 2015", "JUN 24, 2015", "SEP 10, 2015", "JUN 9, 2015", "MAY 28, 2015", "MAY 20, 2015", "MAY 11, 2015", "MAY 8, 2015", "MAY 4, 2015", "APR 30, 2015", "JUN 11, 2015", "APR 21, 2015", "APR 17, 2015", "MAR 25, 2015", "FEB 25, 2015", "FEB 25, 2015", "FEB 19, 2015", "FEB 19, 2015", "APR 22, 2015", "FEB 12, 2015", "FEB 11, 2015", "FEB 10, 2015", "FEB 8, 2015", "JAN 23, 2015", "JAN 21, 2015", "JAN 14, 2015", "FEB 18, 2015", "JAN 8, 2015", "JAN 2, 2015", "DEC 19, 2014", "DEC 19, 2014", "DEC 12, 2014", "DEC 8, 2014", "DEC 8, 2014", "JAN 13, 2015", "NOV 21, 2014", "NOV 18, 2014", "NOV 14, 2014", "NOV 8, 2014", "NOV 3, 2014", "OCT 30, 2014", "OCT 30, 2014", "NOV 25, 2014", "OCT 1, 2014", "SEP 29, 2014", "SEP 29, 2014", "SEP 25, 2014", "SEP 24, 2014", "SEP 18, 2014", "SEP 5, 2014", "OCT 23, 2014", "OCT 1, 2014", "AUG 12, 2014", "AUG 5, 2014", "AUG 4, 2014", "JUL 22, 2014", "JUN 24, 2014", "AUG 26, 2014", "AUG 19, 2014", "MAY 23, 2014", "MAY 20, 2014", "APR 23, 2014", "APR 9, 2014", "APR 3, 2014", "MAR 26, 2014", "JUN 12, 2014", "FEB 26, 2014", "FEB 11, 2014", "FEB 11, 2014", "JAN 20, 2014", "JAN 9, 2014", "DEC 17, 2013", "DEC 17, 2013", "FEB 28, 2014", "NOV 27, 2013", "OCT 15, 2013", "OCT 7, 2013", "OCT 7, 2013", "AUG 6, 2013", "JUN 26, 2013", "JUN 25, 2013", "DEC 6, 2013", "JUN 11, 2013", "MAY 20, 2013", "MAY 16, 2013", "MAY 8, 2013", "MAY 7, 2013", "APR 26, 2013", "APR 5, 2013", "JUN 17, 2013", "MAR 19, 2013", "FEB 13, 2013", "FEB 12, 2013", "FEB 4, 2013", "JAN 29, 2013", "JAN 25, 2013", "JAN 8, 2013", "MAR 27, 2013", "SEP 3, 2012", "JUN 28, 2012", "JUN 11, 2012", "JAN 9, 2012", "NOV 16, 2011", "NOV 6, 2011", "OCT 6, 2011", "SEP 10, 2012", "SEP 3, 2012", "AUG 23, 2011", "JUL 12, 2011", "JUL 12, 2011", "JUN 22, 2011", "DEC 6, 2010", "DEC 6, 2010", "SEP 23, 2011", "NOV 30, 2009", "OCT 26, 2010"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/seattle-genetics-reaches-analyst-target-price-2020-06-09", "https://www.nasdaq.com/articles/seattle-genetics-to-present-at-goldman-sachs-global-healthcare-conference-webcast-at-11%3A20", "https://www.nasdaq.com/articles/seattle-genetics-reports-positive-results-from-her2climb-trial-of-tukysa-2020-05-29", "https://www.nasdaq.com/articles/ibb-ilmn-sgen-alxn%3A-etf-inflow-alert-2020-05-26", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-for-july-17th-2020-05-15", "https://www.nasdaq.com/articles/xbi-mrna-regn-sgen%3A-etf-inflow-alert-2020-05-13", "https://www.nasdaq.com/articles/seattle%3A-tukysa-approved-in-switzerland-to-treat-her2-positive-breast-cancer-2020-05-12", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-01-2020%3A-imgnsgenmohmglnathx-2020-05-01", "https://www.nasdaq.com/articles/seattle-genetics-reaches-analyst-target-price-2020-06-09", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-01-2020%3A-sgenmohmglnathx-2020-05-01", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-wdc-sgen-2020-05-01", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-seattle-genetics-inc.-q1-earnings-report-2020-04-30", "https://www.nasdaq.com/articles/seattle-genetics-q1-20-earnings-conference-call-at-4%3A30-pm-et-2020-04-30", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-for-december-18th-2020-04-23", "https://www.nasdaq.com/articles/is-it-too-late-to-buy-shares-of-seattle-genetics-2020-04-23", "https://www.nasdaq.com/articles/with-fda-approvals-in-hand-these-2-biotech-stocks-are-on-wall-streets-radar-2020-04-21", "https://www.nasdaq.com/articles/seattle-genetics-inc-sgen-q1-2020-earnings-call-transcript-2020-05-01", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-ual-sgen-2020-04-16", "https://www.nasdaq.com/articles/seattle-genetics-sgen-merits-attention-2020-04-13", "https://www.nasdaq.com/articles/seattle-genetics-reaches-analyst-target-price-2020-04-07", "https://www.nasdaq.com/articles/immunomedics-halts-phase-3-trial-of-breast-cancer-drug-because-of-compelling-efficacy-2020", "https://www.nasdaq.com/articles/takeda-pharma-reports-positive-chmp-opinion-for-adcetris-quick-facts-2020-03-31", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-for-may-15th-2020-03-27", "https://www.nasdaq.com/articles/fxh-dxcm-alny-sgen%3A-large-inflows-detected-at-etf-2020-03-25", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-co-diagnostics-xeris-pharma-cyclacel-pharma-2020-04-20", "https://www.nasdaq.com/articles/rsi-alert%3A-seattle-genetics-sgen-now-oversold-2020-03-13", "https://www.nasdaq.com/articles/6-quality-biotech-stocks-on-sale-now-2020-03-06", "https://www.nasdaq.com/articles/mondays-etf-with-unusual-volume%3A-ftls-2020-03-02", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-sgen-jd-2020-03-02", "https://www.nasdaq.com/articles/study-finds-breast-cancer-risk-can-rise-by-50-for-women-who-drink-a-cup-of-milk-every-day", "https://www.nasdaq.com/articles/fda-delays-decision-on-hrtx-drug-kpti-on-watch-admp-to-resubmit-nda-in-q2-2020-02-19", "https://www.nasdaq.com/articles/is-seattle-genetics-stock-a-buy-2020-02-17", "https://www.nasdaq.com/articles/how-to-invest-for-every-scenario-2020-03-23", "https://www.nasdaq.com/articles/seattle-genetics-astellas-and-merck-hit-a-bladder-cancer-bullseye-2020-02-11", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-meli-tmus-2020-02-11", "https://www.nasdaq.com/articles/is-takeda-pharmaceutical-company-stock-a-buy-2020-02-11", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-tcom-tsla-2020-02-10", "https://www.nasdaq.com/articles/seattle-genetics-inc-sgen-q4-2019-earnings-call-transcript-2020-02-07", "https://www.nasdaq.com/articles/seattle-genetics-smashes-wall-street-estimates-in-q4-but-its-2020-guidance-disappoints", "https://www.nasdaq.com/articles/3-canadian-biotechs-to-consider-buying-today-2020-02-07", "https://www.nasdaq.com/articles/seattle-genetics-experimental-breast-cancer-drug-receives-priority-review-from-the-fda", "https://www.nasdaq.com/articles/seattle-genetics-issues-outlook-2020-02-06", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-seattle-genetics-inc.-q4-earnings-report-2020-02-06", "https://www.nasdaq.com/articles/seattle-genetics-q4-19-earnings-conference-call-at-4%3A30-pm-et-2020-02-06", "https://www.nasdaq.com/articles/sgen-crosses-above-average-analyst-target-2020-02-06", "https://www.nasdaq.com/articles/2-top-healthcare-stocks-to-buy-right-now-2020-02-04", "https://www.nasdaq.com/articles/seattle-genetics-%3A-ema-validates-maa-for-tucatinib-2020-01-31", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-right-now-2020-01-30", "https://www.nasdaq.com/articles/seattle-genetics-reports-q4-earnings-results-2020-02-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-21-2020%3A-icccgnpxaznsgenadxs-2020-01-21", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-21-2020%3A-gnpxaznsgenadxs-2020-01-21", "https://www.nasdaq.com/articles/seattle-genetics-achieves-milestone-on-eu-approval-of-roches-polivy-2020-01-21", "https://www.nasdaq.com/articles/are-biotech-stocks-due-for-a-correction-in-2020-2020-01-15", "https://www.nasdaq.com/articles/seattle-genetics-to-present-at-j.p.-morgan-conference-webcast-at-5%3A30-pm-et-2020-01-13", "https://www.nasdaq.com/articles/seattle-genetics-is-now-oversold-sgen-2020-01-13", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-sgen-tsla-2020-01-13", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-ntap-tcom-2020-01-28", "https://www.nasdaq.com/articles/these-3-biotech-stocks-could-be-top-stocks-in-2020-2020-01-11", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-experiences-big-outflow-2020-01-08", "https://www.nasdaq.com/articles/is-puma-biotechnology-a-buy-2020-01-08", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-sgen-googl-2020-01-06", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-sgen-tcom-2020-01-02", "https://www.nasdaq.com/articles/first-week-of-february-2020-options-trading-for-seattle-genetics-2019-12-30", "https://www.nasdaq.com/articles/2-healthcare-stocks-that-doubled-in-2019-and-can-still-go-higher-2019-12-30", "https://www.nasdaq.com/articles/why-seattle-genetics-stock-skyrocketed-102-in-2019-2020-01-12", "https://www.nasdaq.com/articles/a-%2420-billion-sweet-spot-in-biotech-2019-12-28", "https://www.nasdaq.com/articles/xbi-icpt-sgen-alny%3A-large-inflows-detected-at-etf-2019-12-27", "https://www.nasdaq.com/articles/3-blockbuster-cancer-drug-launches-to-watch-in-2020-2019-12-24", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-23-2019%3A-sgennvsacbacb.tosrptacor-2019-12-23", "https://www.nasdaq.com/articles/ussg-idna%3A-big-etf-inflows-2019-12-23", "https://www.nasdaq.com/articles/astellas-%3A-fda-approves-padcev-for-metastatic-urothelial-cancer-2019-12-18", "https://www.nasdaq.com/articles/sgen-crosses-above-average-analyst-target-2019-12-16", "https://www.nasdaq.com/articles/2-things-that-will-propel-seattle-genetics-stock-even-higher-in-2020-2019-12-29", "https://www.nasdaq.com/articles/2-breast-cancer-fighting-stocks-to-invest-in-2019-12-06", "https://www.nasdaq.com/articles/seattle-genetics-astellas-merck-to-evaluate-enfortumab-vedotin-plus-keytruda-2019-12-02", "https://www.nasdaq.com/articles/fbt-qgen-sgen-icpt%3A-large-outflows-detected-at-etf-2019-11-25", "https://www.nasdaq.com/articles/stuff-your-ira-with-the-best-etfs-forget-about-em-2019-11-18", "https://www.nasdaq.com/articles/exelixis-stock-regains-its-mojo-2019-11-18", "https://www.nasdaq.com/articles/healthcare-stocks-that-hit-new-highs-arwr-elmd-sgen...-2019-11-14", "https://www.nasdaq.com/articles/heres-why-seattle-genetics-stock-jumped-25.7-in-october-2019-11-07", "https://www.nasdaq.com/articles/gilds-kte-x19-to-face-fda-ntec-drops-as-nvs-walks-away-kzia-on-watch-2019-12-11", "https://www.nasdaq.com/articles/buy-these-2-stocks-to-access-chinas-huge-healthcare-market-2019-11-06", "https://www.nasdaq.com/articles/seattle-genetics-responds-to-daiichi-sankyos-declaratory-judgment-complaint-2019-11-05", "https://www.nasdaq.com/articles/seattle-genetics-inc-sgen-q3-2019-earnings-call-transcript-2019-10-30", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-seattle-genetics-inc.-q3-earnings-report-2019-10-29", "https://www.nasdaq.com/articles/1-no-brainer-pharmaceutical-stock-to-buy-2019-10-29", "https://www.nasdaq.com/articles/5-top-healthcare-etfs-2019-10-26", "https://www.nasdaq.com/articles/4-stocks-battling-breast-cancer-2019-10-26", "https://www.nasdaq.com/articles/sgen-crosses-above-average-analyst-target-2019-11-07", "https://www.nasdaq.com/articles/3-cancer-treatment-stocks-to-buy-right-now-2019-10-23", "https://www.nasdaq.com/articles/is-seattle-genetics-a-good-biotech-stock-to-buy-now-2019-10-22", "https://www.nasdaq.com/articles/healthcare-stocks-that-hit-new-highs-sgen-rcel-reph...-2019-10-22", "https://www.nasdaq.com/articles/odonate-on-the-move-with-contessa-fda-snubs-clsd-its-a-yes-for-azn-vrtx-2019-10-22", "https://www.nasdaq.com/articles/why-petmed-express-seattle-genetics-and-coty-jumped-today-2019-10-21", "https://www.nasdaq.com/articles/5-top-stock-trades-for-tuesday%3A-pins-bac-twtr-2019-10-21", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-fit-safm-sgen-2019-10-21", "https://www.nasdaq.com/articles/first-trust-nyse-arca-biotechnology-index-fund-experiences-big-outflow-2019-10-24", "https://www.nasdaq.com/articles/heres-why-seattle-genetics-climbed-higher-today-2019-10-21", "https://www.nasdaq.com/articles/seattle-genetics-announces-positive-topline-results-from-her2climb-trial-2019-10-21", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xbi-sgen-mdco-arwr-2019-10-16", "https://www.nasdaq.com/articles/2-biotechs-with-approaching-drug-approvals-to-own-today-2019-10-13", "https://www.nasdaq.com/articles/heres-why-puma-biotechnology-tumbled-today-2019-10-08", "https://www.nasdaq.com/articles/heres-why-seattle-genetics-climbed-17.6-in-september-2019-10-08", "https://www.nasdaq.com/articles/10-great-biotech-stocks-to-buy-in-q4-2019-10-07", "https://www.nasdaq.com/articles/mondays-etf-with-unusual-volume%3A-vot-2019-10-21", "https://www.nasdaq.com/articles/winners-and-losers-of-europes-big-cancer-meeting-2019-10-02", "https://www.nasdaq.com/articles/sgen-crosses-above-average-analyst-target-2019-10-01", "https://www.nasdaq.com/articles/why-immunomedics-stock-is-sinking-today-2019-09-30", "https://www.nasdaq.com/articles/heres-why-seattle-genetics-stock-jumped-higher-today-2019-09-30", "https://www.nasdaq.com/articles/xbi-mrtx-sgen-regn%3A-large-inflows-detected-at-etf-2019-09-30", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-27-2019%3A-sgenprpogossvcnx-2019-09-27", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-for-january-2022-2019-09-18", "https://www.nasdaq.com/articles/how-amazon-is-shaking-up-telemedicine-plus-1-winner-and-1-loser-exiting-esmo-2019-10-04", "https://www.nasdaq.com/articles/astellas-pharma%3A-fda-grants-priority-review-for-enfortumab-vedotin-quick-facts-2019-09-16", "https://www.nasdaq.com/articles/seattle-genetics-enters-oversold-territory-sgen-2019-09-10", "https://www.nasdaq.com/articles/seattle-genetics-breaks-below-200-day-moving-average-notable-for-sgen-2019-09-09", "https://www.nasdaq.com/articles/analysts-predict-11-upside-for-the-holdings-of-jkh-2019-08-29", "https://www.nasdaq.com/articles/first-week-of-sgen-october-18th-options-trading-2019-08-20", "https://www.nasdaq.com/articles/3-perfect-10-biotech-companies-to-buy-2019-07-25", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-24-2019%3A-gildghdxefiiewsgen-2019-07-24", "https://www.nasdaq.com/articles/xlrn-pulls-the-plug-on-fshd-study-kpti-well-funded-acrs-up-on-wart-trial-data-2019-09-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-24-2019%3A-antm-sgen-tmo-jnj-pfe-abt-mrk-amgn-2019-07-24", "https://www.nasdaq.com/articles/seattle-genetics-hits-its-second-growth-phase-2019-07-18", "https://www.nasdaq.com/articles/seattle-genetics-sgen-shares-cross-above-200-dma-2019-07-17", "https://www.nasdaq.com/articles/why-seattle-genetics-avrobio-and-first-majestic-silver-jumped-today-2019-07-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-17-2019%3A-adxssgenghsiimrn-2019-07-17", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity%3A-sgen-nus-qcom-2019-07-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-17-2019%3A-sgenghsiimrn-2019-07-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-24-2019%3A-ghdxefiiewsgen-2019-07-24", "https://www.nasdaq.com/articles/seattle-genetics-inc-sgen-q2-2019-earnings-call-transcript-2019-07-17", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-for-july-19th-2019-07-01", "https://www.nasdaq.com/articles/sgen-makes-notable-cross-below-critical-moving-average-2019-06-26", "https://www.nasdaq.com/articles/first-week-of-sgen-august-16th-options-trading-2019-06-26", "https://www.nasdaq.com/articles/peek-under-the-hood%3A-fex-has-10-upside-2019-06-24", "https://www.nasdaq.com/articles/seattle-genetics-sgen-shares-cross-above-200-dma-2019-05-24", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-sgen-roku-stz-2019-05-08", "https://www.nasdaq.com/articles/heres-why-seattle-genetics-rocketed-higher-today-2019-07-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-26-2019%3A-nvomdcorgensgen-2019-04-26", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-26-2019%3A-mdcorgensgen-2019-04-26", "https://www.nasdaq.com/articles/seattle-genetics-inc-sgen-q1-2019-earnings-call-transcript-2019-04-26", "https://www.nasdaq.com/articles/amcas-underlying-holdings-imply-10-gain-potential-2019-04-22", "https://www.nasdaq.com/articles/sgen-makes-notable-cross-below-critical-moving-average-2019-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-11-2019%3A-jnjicptinntsgen-2019-04-11", "https://www.nasdaq.com/articles/health-care-sector-update-04112019-jnjicptinntsgen-2019-04-11-0", "https://www.nasdaq.com/articles/seattle-genetics-growth-tracking-well-2019-04-30", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-26-2019%3A-nvomdcorgensgen-2019-04-26", "https://www.nasdaq.com/articles/health-care-sector-update-04052019-pgnxlivnsgenaqbxon-2019-04-05-0", "https://www.nasdaq.com/articles/health-care-sector-update-04052019-livnsgenaqbxon-2019-04-05-0", "https://www.nasdaq.com/articles/seattle-genetics-astellas-report-positive-cancer-study-data-2019-03-29-0", "https://www.nasdaq.com/articles/seattle-genetics-sgen-down-6.1-since-last-earnings-report%3A-can-it-rebound-2019-03-09", "https://www.nasdaq.com/articles/look-under-hood-pbus-has-10-upside-2019-03-07", "https://www.nasdaq.com/articles/health-care-sector-update-04112019-icptinntsgen-2019-04-11", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-gets-ec-nod-for-label-expansion-2019-02-12", "https://www.nasdaq.com/articles/sgen-crosses-below-key-moving-average-level-2019-02-08", "https://www.nasdaq.com/articles/health-care-sector-update-02082019-apop-sgen-mbot-jnj-pfe-abt-mrk-amgn-2019-02-08", "https://www.nasdaq.com/articles/why-goodyear-tire-rubber-henry-schein-and-seattle-genetics-slumped-today-2019-02-08", "https://www.nasdaq.com/articles/seattle-genetics-sgen-q4-loss-widens-revenues-top-mark-2019-02-08", "https://www.nasdaq.com/articles/health-care-sector-update-02082019-ingnbiocquresgen-2019-02-08", "https://www.nasdaq.com/articles/seattle-genetics-looks-make-adcertis-blockbuster-investors-unimpressed-2019-02-08", "https://www.nasdaq.com/articles/sgen-april-18th-options-begin-trading-2019-02-12", "https://www.nasdaq.com/articles/health-care-sector-update-02082019-biocquresgen-2019-02-08", "https://www.nasdaq.com/articles/seattle-genetics-sgen-q4-2018-earnings-conference-call-transcript-2019-02-08", "https://www.nasdaq.com/articles/earnings-reaction-history-seattle-genetics-inc-600-follow-through-indicator-50-sensitive", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-7-2019-fisv-rsg-ftv-vrsn-msi-dxc-expe-mtd-iac-sgen", "https://www.nasdaq.com/articles/whats-in-the-cards-for-glaxo-gsk-this-earnings-season-2019-02-04", "https://www.nasdaq.com/articles/regeneron-regn-to-report-q4-earnings%3A-is-a-beat-in-store-2019-02-04", "https://www.nasdaq.com/articles/seattle-genetics-sgen-expected-to-beat-earnings-estimates%3A-what-to-know-ahead-of-q4", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-ktos-zayo-sgen-2019-02-08", "https://www.nasdaq.com/articles/health-care-sector-update-02082019-biocquresgen-2019-02-08", "https://www.nasdaq.com/articles/5-biotech-stocks-could-face-ma-next-2019-01-10", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-sgen-2019-01-08", "https://www.nasdaq.com/articles/seattle-genetics-present-jp-morgan-conference-webcast-600-pm-et-2019-01-07", "https://www.nasdaq.com/articles/seattle-genetics-sgen-looks-good%3A-stock-adds-5.6-in-session-2018-11-19", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-gets-breakthrough-therapy-status-2018-11-16", "https://www.nasdaq.com/articles/health-care-sector-update-11162018-amedarna-sgenhcm-2018-11-16", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-september-20th-2019-01-24", "https://www.nasdaq.com/articles/how-parts-add-amca-headed-32-2018-11-09", "https://www.nasdaq.com/articles/seattle-genetics-now-hard-work-begins-2018-10-30", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-june-2019-2018-10-29", "https://www.nasdaq.com/articles/seattle-genetics-sgen-q3-loss-in-line-sales-top-mark-2018-10-26", "https://www.nasdaq.com/articles/heres-why-seattle-genetics-plummeted-today-2018-10-26", "https://www.nasdaq.com/articles/seattle-genetics-inc-breaks-below-200-day-moving-average-notable-sgen-2018-10-26", "https://www.nasdaq.com/articles/seattle-genetics-inc-sgen-q3-2018-earnings-conference-call-transcript-2018-10-26", "https://www.nasdaq.com/articles/health-care-sector-update-11162018-arnauthrsgenhcm-2018-11-16", "https://www.nasdaq.com/articles/how-parts-add-amca-headed-32-2018-11-09", "https://www.nasdaq.com/articles/we-did-math-fxh-can-go-89-2018-10-09", "https://www.nasdaq.com/articles/seattle-genetics-reaches-analyst-target-price-2018-10-02", "https://www.nasdaq.com/articles/first-week-november-16th-options-trading-seattle-genetics-sgen-2018-09-26", "https://www.nasdaq.com/articles/seattle-genetics-reaches-analyst-target-price-2018-08-20", "https://www.nasdaq.com/articles/bayer-plunges-as-monsanto-fined-%24289m-in-roundup-lawsuit-2018-08-14", "https://www.nasdaq.com/articles/spectrum-sppi-earnings-and-sales-miss-estimates-in-q2-2018-08-10", "https://www.nasdaq.com/articles/seattle-genetics-now-oversold-sgen-2018-10-24", "https://www.nasdaq.com/articles/celldex-cldx-q2-earnings-and-revenues-surpass-estimates-2018-08-09", "https://www.nasdaq.com/articles/nektar-nktr-q2-earnings-in-line-product-sales-down-y-y-2018-08-09", "https://www.nasdaq.com/articles/perrigo-prgo-beats-on-q2-earnings-cuts-view-shares-down-2018-08-09", "https://www.nasdaq.com/articles/sarepta-srpt-q2-loss-narrows-exondys-51-drives-sales-2018-08-09", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q2-earnings-sales-beat-shares-rise-2018-08-09", "https://www.nasdaq.com/articles/mallinckrodt-mnk-beats-on-q2-earnings-and-sales-ups-view-2018-08-08", "https://www.nasdaq.com/articles/catalyst-cprx-posts-narrower-than-expected-loss-in-q2-2018-08-08", "https://www.nasdaq.com/articles/endo-endp-beats-on-q2-earnings-sales-raises-guidance-2018-08-09", "https://www.nasdaq.com/articles/vivus-vvus-q2-loss-wider-than-expected-revenues-up-y-y-2018-08-08", "https://www.nasdaq.com/articles/jazz-pharmas-jazz-stock-down-despite-q2-earnings-beat-2018-08-08", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-q2-loss-wider-than-expected-2018-08-07", "https://www.nasdaq.com/articles/medicines-company-mdco-q2-loss-narrows-revenues-tank-y-y-2018-08-02", "https://www.nasdaq.com/articles/ophthotech-opht-q2-loss-narrows-zimura-progress-on-track-2018-08-02", "https://www.nasdaq.com/articles/geron-gern-q2-loss-in-line-revenues-up-y-y-shares-down-2018-08-01", "https://www.nasdaq.com/articles/seattle-genetics-latest-approval-best-yet-2018-07-31", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q2-loss-in-line-revenues-miss-2018-08-08", "https://www.nasdaq.com/articles/health-care-sector-update-07272018-sgennbrvabbvtnxp-2018-07-27", "https://www.nasdaq.com/articles/first-week-sgen-march-2019-options-trading-2018-07-25", "https://www.nasdaq.com/articles/4-biotech-bets-watch-industry-rebounds-month-2018-07-20", "https://www.nasdaq.com/articles/sgen-crosses-above-average-analyst-target-2018-07-20", "https://www.nasdaq.com/articles/10-cancer-fighting-health-care-stocks-buy-2018-07-20", "https://www.nasdaq.com/articles/why-is-seattle-genetics-sgen-up-13.3-since-its-last-earnings-report-2018-05-28", "https://www.nasdaq.com/articles/add-parts-pbus-could-be-worth-30-2018-05-18", "https://www.nasdaq.com/articles/seattle-genetics-sgen-q2-loss-narrows-sales-top-estimates-2018-07-27", "https://www.nasdaq.com/articles/seattle-genetics-accelerates-revenue-growth-earnings-not-so-much-2018-05-02", "https://www.nasdaq.com/articles/why-seattle-genetics-jumped-higher-today-2018-04-27", "https://www.nasdaq.com/articles/seattle-genetics-sgen-q1-earnings-lag-estimates-sales-top-2018-04-27", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-ptgx-down-vrna-up-amgns-repatha-gets-positive-opinion-2018-03-28", "https://www.nasdaq.com/articles/5-biotech-stocks-amazing-pipelines-2018-03-27", "https://www.nasdaq.com/articles/cancer-space-roundup%3A-nvs-tasigna-sgens-adcetris-label-expansions-in-focus-2018-03-23", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-gets-fda-nod-for-label-expansion-2018-03-21", "https://www.nasdaq.com/articles/notable-monday-option-activity-sgen-lmt-fnhc-2018-05-14", "https://www.nasdaq.com/articles/seattle-genetics-sgen-up-8.4-since-earnings-report%3A-can-it-continue-2018-03-08", "https://www.nasdaq.com/articles/sgen-makes-bullish-cross-above-critical-moving-average-2018-02-27", "https://www.nasdaq.com/articles/heres-why-pieris-pharmaceuticals-inc-tanking-2018-02-14", "https://www.nasdaq.com/articles/why-pieris-pharmaceuticals-inc-soaring-today-2018-02-09", "https://www.nasdaq.com/articles/health-care-sector-update-02092018-pacbpirssgenctictndm-2018-02-09", "https://www.nasdaq.com/articles/health-care-sector-update-02092018-pirssgenctictndm-2018-02-09", "https://www.nasdaq.com/articles/seattle-genetics-growing-any-way-it-can-2018-02-08", "https://www.nasdaq.com/articles/celldex-therapeutics-stock-about-skyrocket-2018-03-13", "https://www.nasdaq.com/articles/implied-vv-analyst-target-price-137-2018-02-07", "https://www.nasdaq.com/articles/earnings-reaction-history-seattle-genetics-inc-667-follow-through-indicator-34-sensitive", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-sanofi-seattle-genetics-abbvie-celgene-and-vertex-2018", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-seattle-genetics-sgen-2018-02-05", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-02-03", "https://www.nasdaq.com/articles/biotech-roundup-whos-popping-drug-merger-earnings-news-2018-02-01", "https://www.nasdaq.com/articles/midday-update-wall-street-snaps-back-boeing-keeps-dow-airborne-2018-01-31", "https://www.nasdaq.com/articles/seattle-genetics-sgen-q4-earnings-revenues-top-estimates-2018-02-07", "https://www.nasdaq.com/articles/us-futures-rebound-ahead-fomc-decision-2018-01-31", "https://www.nasdaq.com/articles/close-update-wall-street-recovers-losses-after-fed-stem-two-day-slide-2018-01-31", "https://www.nasdaq.com/articles/heres-why-cascadian-therapeutics-jumped-731-today-2018-01-31", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-performs-well-despite-competition-2018-01-26", "https://www.nasdaq.com/articles/seattle-genetics-sgen-shares-cross-above-200-dma-2018-01-23", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-gets-eu-nod-for-label-expansion-2018-01-23", "https://www.nasdaq.com/articles/will-2018-be-celldex-therapeutics-incs-best-year-yet-2018-01-16", "https://www.nasdaq.com/articles/wall-street-upbeat-mood-ahead-fomc-decision-2018-01-31", "https://www.nasdaq.com/articles/biotech-stock-roundup-gwph-submits-epidiolex-eu-sangamo-inks-deal-pfizer-2018-01-04", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-sbla-gets-fda-priority-review-2018-01-03", "https://www.nasdaq.com/articles/first-week-february-2018-options-trading-seattle-genetics-sgen-2017-12-20", "https://www.nasdaq.com/articles/thursdays-etf-movers-fdn-fbt-2017-12-14", "https://www.nasdaq.com/articles/why-seattle-genetics-inc-fell-today-2017-12-11", "https://www.nasdaq.com/articles/immunomedics-data-good-news-seattle-genetics-too-2017-12-08", "https://www.nasdaq.com/articles/why-immunomedics-inc-soaring-today-2017-12-06", "https://www.nasdaq.com/articles/cancer-space-update%3A-new-regulatory-status-for-3-major-drugs-2018-01-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-gwph-submits-epidiolex-eu-sangamo-inks-deal-pfizer-2018-01-04", "https://www.nasdaq.com/articles/notable-monday-option-activity-sgen-v-ibkr-2017-11-27", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-gets-fda-nod-for-label-expansion-2017-11-13", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xbi-alny-pbyi-sgen-2017-11-07", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-sgen-cytk-wrd-2017-11-01", "https://www.nasdaq.com/articles/seattle-genetics-inc-double-digit-revenue-growth-best-yet-come-2017-11-01", "https://www.nasdaq.com/articles/xbi-alny-pbyi-sgen-etf-inflow-alert-2017-10-31", "https://www.nasdaq.com/articles/market-moving-news-tap-seattle-genetics-2017-12-04", "https://www.nasdaq.com/articles/seattle-genetics-sgen-loss-narrows-in-q3-revenues-beat-2017-10-27", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-agenus-agen-this-earnings-season-2017-10-25", "https://www.nasdaq.com/articles/should-you-sell-seattle-genetics-sgen-earnings-2017-10-25", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-alexion-alxn-this-earnings-season-2017-10-24", "https://www.nasdaq.com/articles/xbi-alny-clvs-sgen-etf-outflow-alert-2017-10-23", "https://www.nasdaq.com/articles/cancer-space-update%3A-lung-breast-cancer-studies-in-focus-2017-10-13", "https://www.nasdaq.com/articles/seattle-genetics-inks-clinical-collaborations-for-cancer-drug-2017-10-12", "https://www.nasdaq.com/articles/ibd-rating-upgrades-seattle-genetics-flashes-improved-price-strength-2017-10-30", "https://www.nasdaq.com/articles/seattle-genetics-begins-phase-ii-study-of-cancer-candidate-2017-10-11", "https://www.nasdaq.com/articles/why-snap-seattle-genetics-and-pretium-resources-jumped-today-2017-10-11", "https://www.nasdaq.com/articles/drugmaker-hit-4-month-high-collaboration-dows-merck-2017-10-11", "https://www.nasdaq.com/articles/cancer-space-last-week-update%3A-pipeline-expansion-in-focus-2017-10-09", "https://www.nasdaq.com/articles/seattle-genetics-reaches-analyst-target-price-2017-10-03", "https://www.nasdaq.com/articles/company-news-for-oct-3-2017-2017-10-03", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-gets-breakthrough-therapy-status-2017-10-03", "https://www.nasdaq.com/articles/sgen-makes-bullish-cross-above-critical-moving-average-2017-10-11", "https://www.nasdaq.com/articles/green-monday-capital-markets-around-globe-2017-10-02", "https://www.nasdaq.com/articles/bristol-myers-bmy-opdivo-gets-approval-for-liver-cancer-2017-09-25", "https://www.nasdaq.com/articles/bristol-myers-opdivo-study-meets-early-success-stock-up-2017-09-08", "https://www.nasdaq.com/articles/pfizers-acute-leukemia-drug-mylotarg-approved-by-the-fda-2017-09-04", "https://www.nasdaq.com/articles/analysts-predict-12-gains-ahead-fbt-2017-08-31", "https://www.nasdaq.com/articles/first-week-sgen-october-20th-options-trading-2017-08-22", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-granted-priority-review-by-fda-2017-08-17", "https://www.nasdaq.com/articles/seattle-genetics-sgen-in-focus%3A-stock-moves-7.9-higher-2017-10-03", "https://www.nasdaq.com/articles/immunogen-inc-earnings-what-goes-must-come-down-2017-07-31", "https://www.nasdaq.com/articles/seattle-genetics-sgen-q2-loss-narrower-than-expected-2017-07-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-merck-celgene-gilead-sciences-seattle-genetics-and", "https://www.nasdaq.com/articles/5-drug-stocks-well-poised-to-beat-q2-earnings-estimates-2017-07-13", "https://www.nasdaq.com/articles/pfizers-mylotarg-recommended-by-fda-advisory-committee-2017-07-12", "https://www.nasdaq.com/articles/bristol-myers-opdivo-superior-to-yervoy-in-melanoma-study-2017-07-06", "https://www.nasdaq.com/articles/roches-rhhby-leukemia-drug-gets-prime-status-in-eu-2017-06-30", "https://www.nasdaq.com/articles/seattle-genetics-inc-expanded-sales-their-way-fda-willing-2017-07-31", "https://www.nasdaq.com/articles/seattle-genetics-sgen-reports-positive-data-for-adcetris-2017-06-27", "https://www.nasdaq.com/articles/mid-day-update-us-stocks-mixed-oil-supply-worries-linger-data-weakens-2017-06-26", "https://www.nasdaq.com/articles/seattle-genetics-enters-oversold-territory-sgen-2017-06-26", "https://www.nasdaq.com/articles/pre-market-most-active-jun-26-2017-azn-vrx-mu-sgen-p-qqq-bac-uslv-fb-cb-aapl-tsm-2017-06", "https://www.nasdaq.com/articles/why-frontier-communications-seattle-genetics-and-arconic-slumped-today-2017-06-26", "https://www.nasdaq.com/articles/why-shares-seattle-genetics-inc-got-whacked-today-2017-06-26", "https://www.nasdaq.com/articles/seattle-genetics-sgen-submits-bla-to-fda-for-cancer-drug-2017-06-21", "https://www.nasdaq.com/articles/fbts-underlying-holdings-could-mean-11-gain-potential-2017-06-28", "https://www.nasdaq.com/articles/bristol-myers-opdivo-positive-in-phase-ii-study-checkmate-205-2017-06-19", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-eqt-buy-rice-energy-67b-2017-06-19", "https://www.nasdaq.com/articles/health-care-sector-update-06192017-pkinvdqsyksgen-2017-06-19", "https://www.nasdaq.com/articles/health-care-sector-update-06192017-clvsnvdqsyksgen-2017-06-19", "https://www.nasdaq.com/articles/baker-bros-advisors-lp-buys-incyte-corp-avexis-inc-la-jolla-pharmaceutical-co-sells-abbvie", "https://www.nasdaq.com/articles/health-care-sector-update-06162017-sgenclsnidxg-2017-06-16", "https://www.nasdaq.com/articles/seattle-genetics-reports-updated-results-on-cancer-drug-2017-06-06", "https://www.nasdaq.com/articles/seattle-genetics-halts-phase-iii-study-on-leukemia-drug-2017-06-20", "https://www.nasdaq.com/articles/commit-purchase-seattle-genetics-50-earn-106-annualized-using-options-2017-05-26", "https://www.nasdaq.com/articles/seattle-genetics-inc.-sgen-leads-10-notable-investor-filings-2017-05-18", "https://www.nasdaq.com/articles/immunogen-inc-begins-forward-i-investors-wait-2017-05-10", "https://www.nasdaq.com/articles/head-scratching-reason-immunomedics-rose-much-12-2017-05-08", "https://www.nasdaq.com/articles/why-immunomedics-mercadolibre-and-pearson-jumped-today-2017-05-05", "https://www.nasdaq.com/articles/health-care-sector-update-05052017-rglsimmusgenaphb-2017-05-05", "https://www.nasdaq.com/articles/why-immunomedics-inc-rocketed-today-2017-05-05", "https://www.nasdaq.com/articles/bristol-myers-presents-data-on-immuno-oncology-drug-opdivo-2017-06-05", "https://www.nasdaq.com/articles/seattle-genetics-inc-earnings-solid-quarter-investors-wait-2017-05-01", "https://www.nasdaq.com/articles/seattle-genetics-sgen-q1-loss-widens-sales-top-estimates-2017-04-28", "https://www.nasdaq.com/articles/why-immunomedics-inc-got-hammered-today-2017-04-21", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-april-3rd-2017-04-03", "https://www.nasdaq.com/articles/why-shares-immunomedics-inc-are-astounding-89-2017-2017-03-28", "https://www.nasdaq.com/articles/battle-boardroom-whats-next-immunomedics-2017-03-28", "https://www.nasdaq.com/articles/billionaires-best-healthcare-stock-picks-2017-so-far-2017-03-21", "https://www.nasdaq.com/articles/health-care-sector-update-05052017-fldmimmuaphb-2017-05-05", "https://www.nasdaq.com/articles/why-immunomedics-inc-jumped-higher-today-2017-03-09", "https://www.nasdaq.com/articles/why-marathon-oil-signet-jewelers-and-immunomedics-jumped-today-2017-03-09", "https://www.nasdaq.com/articles/immunomedics-immu-stock-soars-after-deal-seattle-genetics-halted-2017-03-09", "https://www.nasdaq.com/articles/seattle-genetics-sgen%3A-fda-lifts-hold-on-trial-of-aml-drug-2017-03-08", "https://www.nasdaq.com/articles/arch-coal-seattle-genetics-skyworks-solutions-texas-instruments-and-apple-highlighted-as", "https://www.nasdaq.com/articles/3-biotech-long-shots-boom-or-bust-2017-02-24", "https://www.nasdaq.com/articles/first-week-april-21st-options-trading-seattle-genetics-2017-02-22", "https://www.nasdaq.com/articles/seattle-genetics-sgen-up-8.2-since-earnings-report%3A-can-it-continue-2017-03-14", "https://www.nasdaq.com/articles/will-seattle-genetics-deal-immunomedics-get-scuttled-2017-02-12", "https://www.nasdaq.com/articles/mid-day-market-update-infinera-surges-earnings-beat-channeladvisor-shares-plunge-2017-02", "https://www.nasdaq.com/articles/health-care-sector-update-02102017-tconimmusgenbstg-2017-02-10", "https://www.nasdaq.com/articles/seattle-genetics-sgen-loss-wider-than-expected-in-q4-revenues-miss-2017-02-10", "https://www.nasdaq.com/articles/health-care-sector-update-02102017-onvoimmusgenbstg-2017-02-10", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-9-2017-nvda-tri-atvi-cern-expe-mhk-agu-wu-sgen-vrsn", "https://www.nasdaq.com/articles/3-mid-cap-biotech-stocks-buy-february-2017-01-29", "https://www.nasdaq.com/articles/seattle-genetics-earnings-waiting-echelon-2017-02-13", "https://www.nasdaq.com/articles/5-expensive-drugs-could-end-trumps-crosshairs-2017-01-18", "https://www.nasdaq.com/articles/after-ariads-acquisition-these-3-cancer-drug-stocks-could-be-next-2017-01-10", "https://www.nasdaq.com/articles/biotech-stocks-what-watch-2017-2016-12-29", "https://www.nasdaq.com/articles/seattle-genetics-acute-myeloid-leukemia-drug-on-fda-hold-2016-12-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-biogenionis-drug-seattle-genetics-hit-clinical-hold-2016-12", "https://www.nasdaq.com/articles/why-seattle-genetics-inc-got-clobbered-today-2016-12-27", "https://www.nasdaq.com/articles/health-care-sector-update-12272016-sgen-ions-jnj-pfe-abt-mrk-amgn-2016-12-27", "https://www.nasdaq.com/articles/lagoda-investment-management-lp-buys-texas-pacific-land-trust-microsoft-corp-coca-cola-co", "https://www.nasdaq.com/articles/what-happened-stock-market-today-2016-12-27", "https://www.nasdaq.com/articles/why-seattle-genetics-inc.-sgen-endologix-inc.-elgx-and-amphastar-pharmaceuticals-inc-amph", "https://www.nasdaq.com/articles/health-care-sector-update-12272016-sgencapnengx-2016-12-27", "https://www.nasdaq.com/articles/why-seattle-genetics-stock-surged-higher-november-2016-12-09", "https://www.nasdaq.com/articles/after-hours-most-active-nov-30-2016-fdc-info-msft-bac-sfun-bmy-aapl-siri-intc-nrg-epd-sgen", "https://www.nasdaq.com/articles/fridays-etf-unusual-volume-fny-2016-11-18", "https://www.nasdaq.com/articles/why-these-biotechs-saw-double-digit-gains-today-2016-11-09", "https://www.nasdaq.com/articles/pre-market-most-active-dec-27-2016-sdrl-dnr-chk-db-swn-vale-cnat-nvda-sgen-mu-sgyp-clne", "https://www.nasdaq.com/articles/health-care-sector-update-11082016-sgen-2016-11-08", "https://www.nasdaq.com/articles/insiders-buy-herbalife-sell-mastercard-2016-11-05", "https://www.nasdaq.com/articles/4-medical-and-biotech-stocks-watch-2016-11-02", "https://www.nasdaq.com/articles/5-years-after-adcetris-approval-seattle-genetics-inc-still-focused-pipeline-2016-10-31", "https://www.nasdaq.com/articles/seattle-genetics-sgen-loss-narrower-than-expected-in-q3-2016-10-28", "https://www.nasdaq.com/articles/first-week-june-2017-options-trading-seattle-genetics-sgen-2016-10-26", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-fxh-sgen-uthr-lpnt-2016-10-19", "https://www.nasdaq.com/articles/fxh-wcg-sgen-uthr-large-outflows-detected-etf-2016-11-08", "https://www.nasdaq.com/articles/3-biotechs-could-be-ma-targets-2016-09-24", "https://www.nasdaq.com/articles/15000-shares-bought-seattle-genetics-director-2016-09-09", "https://www.nasdaq.com/articles/wednesdays-etf-movers-fbt-gdxj-2016-09-07", "https://www.nasdaq.com/articles/we-did-math-bbh-can-go-136-2016-08-26", "https://www.nasdaq.com/articles/immunogen-inc-gets-fda-green-light-its-trial-design-2016-08-09", "https://www.nasdaq.com/articles/seattle-genetics-inc-making-most-it-and-then-some-2016-07-29", "https://www.nasdaq.com/articles/seattle-genetics-sgen-loss-narrower-than-expected-in-q2-2016-07-27", "https://www.nasdaq.com/articles/sgen-crosses-above-average-analyst-target-2016-10-11", "https://www.nasdaq.com/articles/whats-store-these-5-drug-stocks-q2-earnings-2016-07-25", "https://www.nasdaq.com/articles/3-stocks-were-buying-again-2016-07-21", "https://www.nasdaq.com/articles/3-primary-ways-researchers-are-combatting-cancer-2016-07-16", "https://www.nasdaq.com/articles/5-things-celldex-therapeutics-inc-wants-you-know-2016-07-13", "https://www.nasdaq.com/articles/abbvies-abt-414-gets-rare-pediatric-disease-status-in-u.s.-2016-07-12", "https://www.nasdaq.com/articles/seattle-genetics-takeda-adectris-label-expanded-in-the-eu-2016-07-07", "https://www.nasdaq.com/articles/bargain-buys-these-3-biopharma-stocks-are-all-down-big-2016-2016-06-30", "https://www.nasdaq.com/articles/wednesdays-etf-movers-xbi-fxn-2016-07-27", "https://www.nasdaq.com/articles/seattle-genetics-starts-trial-on-acute-myeloid-leukemia-drug-2016-05-26", "https://www.nasdaq.com/articles/july-15th-options-now-available-seattle-genetics-sgen-2016-05-23", "https://www.nasdaq.com/articles/3-cancer-fighting-stocks-making-waves-in-the-markets-2016-05-20", "https://www.nasdaq.com/articles/seattle-genetics-breaks-above-200-day-moving-average-bullish-sgen-2016-05-19", "https://www.nasdaq.com/articles/commit-buy-seattle-genetics-25-earn-85-annualized-using-options-2016-05-06", "https://www.nasdaq.com/articles/taking-inventory-seattle-genetics-inc-earnings-2016-05-04", "https://www.nasdaq.com/articles/seattle-genetics-sgen-posts-wider-than-expected-q1-loss-2016-04-29", "https://www.nasdaq.com/articles/seattle-genetics-has-been-heating-time-buy-2016-06-10", "https://www.nasdaq.com/articles/analysts-anticipate-13-gains-ahead-holdings-pxmg-2016-04-27", "https://www.nasdaq.com/articles/seattle-genetics-sgen-shares-cross-above-200-dma-2016-04-25", "https://www.nasdaq.com/articles/5-biotech-stocks-to-bet-on-this-earnings-season-2016-04-25", "https://www.nasdaq.com/articles/will-perrigo-prgo-surprise-earnings-estimates-in-q1-2016-04-15", "https://www.nasdaq.com/articles/why-seattle-genetics-inc-stock-rose-10-march-2016-04-12", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-xbi-the-best-biotech-investment-now-2016-03-24", "https://www.nasdaq.com/articles/insiders-roundup-theravance-biopharma-western-gas-upland-software-2016-03-19", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-seattle-genetics-sgen-2016-04-27", "https://www.nasdaq.com/articles/seattle-genetics-initiates-phase-i-ii-study-on-sgn-cd33a-2016-02-23", "https://www.nasdaq.com/articles/top-insider-trades-past-week-2016-02-20", "https://www.nasdaq.com/articles/sgen-insiders-vs-shorts-2016-02-18", "https://www.nasdaq.com/articles/seattle-genetics-sgen-q4-loss-wider-than-expected-2016-02-10", "https://www.nasdaq.com/articles/health-care-sector-update-02102016-sgen-tear-usna-2016-02-10", "https://www.nasdaq.com/articles/seattle-genetics-inc-grows-sales-waits-data-2016-02-10", "https://www.nasdaq.com/articles/earnings-reaction-history-seattle-genetics-inc-500-follow-through-indicator-45-sensitive", "https://www.nasdaq.com/articles/implied-pxmg-analyst-target-price-33-2016-03-11", "https://www.nasdaq.com/articles/fridays-etf-movers-xop-fbt-2016-01-29", "https://www.nasdaq.com/articles/friday-sector-laggards-biotechnology-shipping-stocks-2016-01-29", "https://www.nasdaq.com/articles/affimed-merck-ink-deal-for-afm13-keytruda-combination-2016-01-27", "https://www.nasdaq.com/articles/last-weeks-best-healthcare-etf-2016-01-02", "https://www.nasdaq.com/articles/seattle-genetics-bristol-myers-begin-adcetris-opdivo-study-2015-12-24", "https://www.nasdaq.com/articles/seattle-genetics-breaks-above-200-day-moving-average-bullish-sgen-2015-12-16", "https://www.nasdaq.com/articles/relative-strength-alert-seattle-genetics-2016-02-08", "https://www.nasdaq.com/articles/use-options-chance-buy-sgen-23-discount-2015-11-10", "https://www.nasdaq.com/articles/seattle-genetics-inc-earnings-extending-runway-2015-11-03", "https://www.nasdaq.com/articles/seattle-genetics-sgen-loss-widens-y-y-outlook-upped-2015-10-30", "https://www.nasdaq.com/articles/health-care-sector-update-10302015-gild-sgen-2015-10-30", "https://www.nasdaq.com/articles/sgen-crosses-above-key-moving-average-level-2015-10-23", "https://www.nasdaq.com/articles/health-care-sector-update-10192015-ljpc-galt-sgen-2015-10-19", "https://www.nasdaq.com/articles/sgen-crosses-below-key-moving-average-level-2015-11-24", "https://www.nasdaq.com/articles/just-upgrades-and-downgrades-2015-11-18", "https://www.nasdaq.com/articles/insiders-are-buying-barnes-noble-2015-09-18", "https://www.nasdaq.com/articles/global-imbalances-and-chinese-economy-john-mauldin-2015-09-18", "https://www.nasdaq.com/articles/seattle-genetics-sgen-catches-eye%3A-stock-moves-up-8.3-2015-09-14", "https://www.nasdaq.com/articles/health-care-sector-update-09142015-sgen-tbph-vrtx-2015-09-14", "https://www.nasdaq.com/articles/pre-market-most-active-sep-11-2015-bhp-mrvl-alu-nep-azn-xiv-tvix-sgen-sdrl-aapl-bac-fb", "https://www.nasdaq.com/articles/health-care-sector-update-09112015-med-pfe-sgen-2015-09-11", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-november-20th-2015-09-25", "https://www.nasdaq.com/articles/heres-why-baker-bros-are-gobbling-emerging-cancer-company-2015-09-05", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-label-expanded-in-the-u.s.-2015-08-18", "https://www.nasdaq.com/articles/health-care-sector-update-08182015-sgenomeraveo-2015-08-18", "https://www.nasdaq.com/articles/still-profitless-seattle-genetics-2015-07-31", "https://www.nasdaq.com/articles/seattle-genetics-sgen-loss-widens-in-q2-ups-2015-view-analyst-blog-2015-07-31", "https://www.nasdaq.com/articles/first-week-sgen-march-2016-options-trading-2015-07-21", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-august-21st-2015-06-24", "https://www.nasdaq.com/articles/health-care-sector-update-09102015-sgen-cytx-ljpc-2015-09-10", "https://www.nasdaq.com/articles/seattle-genetics-unum-therapeutics-tie-up-for-cancer-drugs-analyst-blog-2015-06-09", "https://www.nasdaq.com/articles/seattle-genetics-larger-sp-500-component-tenet-healthcare-2015-05-28", "https://www.nasdaq.com/articles/first-week-july-17th-options-trading-seattle-genetics-sgen-2015-05-20", "https://www.nasdaq.com/articles/seattle-genetics-sgen-in-focus%3A-stock-up-8.1-tale-of-the-tape-2015-05-11", "https://www.nasdaq.com/articles/seattle-genetics-director-buys-more-1-million-shares-2015-05-08", "https://www.nasdaq.com/articles/seattle-genetics-posts-narrower-than-expected-loss-in-q1-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/seattle-genetics-inc-posts-solid-first-quarter-revenue-raises-expense-guidance-2015-04-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-vertex-celgene-seattle-genetics-and-sage", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-under-review-for-new-indication-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-sgen-2015-04-17", "https://www.nasdaq.com/articles/sgen-crosses-below-key-moving-average-level-2015-03-25", "https://www.nasdaq.com/articles/seattle-genetics-larger-sp-500-component-noble-2015-02-25", "https://www.nasdaq.com/articles/seattle-genetics-sgen-shares-cross-above-200-dma-2015-02-25", "https://www.nasdaq.com/articles/seattle-genetics-sgen-filed-supplemental-bla-for-adcetris-analyst-blog-2015-02-19", "https://www.nasdaq.com/articles/thursdays-etf-movers-pbe-icf-2015-02-19", "https://www.nasdaq.com/articles/first-week-december-18th-options-trading-seattle-genetics-2015-04-22", "https://www.nasdaq.com/articles/ceiling-seen-seattle-genetics-2015-02-12", "https://www.nasdaq.com/articles/seattle-genetics-posts-narrower-than-expected-loss-in-q4-analyst-blog-2015-02-11", "https://www.nasdaq.com/articles/seattle-genetics-inc-exceeds-expecations-2015-02-10", "https://www.nasdaq.com/articles/which-biotech-stock-should-pfizer-inc-buy-2015-02-08", "https://www.nasdaq.com/articles/first-week-sgen-september-18th-options-trading-2015-01-23", "https://www.nasdaq.com/articles/commit-buy-seattle-genetics-25-earn-85-annualized-using-options-2015-01-21", "https://www.nasdaq.com/articles/eli-lilly-inks-oncology-deals-with-merck-bristol-myers-analyst-blog-2015-01-14", "https://www.nasdaq.com/articles/seattle-genetics-sea-cd40-enters-phase-i-for-solid-tumors-analyst-blog-2015-02-18", "https://www.nasdaq.com/articles/why-seattle-genetics-inc-stock-dove-12-december-2015-01-08", "https://www.nasdaq.com/articles/new-biotech-etf-alps-2015-01-02", "https://www.nasdaq.com/articles/seattle-genetics-initiates-phase-ib-study-on-leukemia-drug-analyst-blog-2014-12-19", "https://www.nasdaq.com/articles/bull-day-seattle-genetics-sgen-bull-day-2014-12-19", "https://www.nasdaq.com/articles/dow-30-stock-roundup-chevron-acquires-new-zealand-exploration-rights-merck-announces", "https://www.nasdaq.com/articles/bristol-myers-posts-positive-opdivo-hodgkin-lymphoma-data-analyst-blog-2014-12-08", "https://www.nasdaq.com/articles/mercks-new-oncology-product-positive-in-early-study-analyst-blog-2014-12-08", "https://www.nasdaq.com/articles/seattle-genetics-bristol-myers-to-study-adcetris-opdivo-analyst-blog-2015-01-13", "https://www.nasdaq.com/articles/seattle-genetics-inc-sgen-new-analyst-report-zacks-equity-research-zacks-equity-research", "https://www.nasdaq.com/articles/why-the-earnings-streak-will-continue-for-seattle-genetics-sgen-tale-of-the-tape-2014-11", "https://www.nasdaq.com/articles/fridays-etf-movers-gdxj-bbh-2014-11-14", "https://www.nasdaq.com/articles/3-biotech-stocks-watch-november-2014-11-08", "https://www.nasdaq.com/articles/seattle-genetics-gains-on-narrower-than-expected-q3-loss-analyst-blog-2014-11-03", "https://www.nasdaq.com/articles/seattle-genetics-inc-posts-record-adcetris-sales-2014-10-30", "https://www.nasdaq.com/articles/earnings-reaction-history-seattle-genetics-inc-250-follow-through-indicator-59-sensitive", "https://www.nasdaq.com/articles/seattle-genetics-larger-sp-500-component-nabors-industries-2014-11-25", "https://www.nasdaq.com/articles/seattle-genetics-takeda-reveal-impressive-adcetris-data-analyst-blog-2014-10-01", "https://www.nasdaq.com/articles/sector-update-health-care-shares-sink-pre-market-trade-2014-09-29", "https://www.nasdaq.com/articles/sector-update-health-care-2014-09-29-0", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-positive-in-durability-analysis-analyst-blog-2014-09-25", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-november-22nd-2014-09-24", "https://www.nasdaq.com/articles/merck-kgaa-teams-up-with-sutro-for-adcs-targeting-cancer-analyst-blog-2014-09-18", "https://www.nasdaq.com/articles/seattle-genetics-sgen-shares-cross-below-200-dma-2014-09-05", "https://www.nasdaq.com/articles/first-week-june-2015-options-trading-seattle-genetics-sgen-2014-10-23", "https://www.nasdaq.com/articles/seattle-genetics-takeda-reveal-impressive-adcetris-data-analyst-blog-2014-10-01", "https://www.nasdaq.com/articles/seattle-genetics-sgen-shares-cross-above-200-dma-2014-08-12", "https://www.nasdaq.com/articles/abbvies-abt-414-receives-orphan-drug-status-in-u.s.-and-eu-analyst-blog-2014-08-05", "https://www.nasdaq.com/articles/seattle-genetics-up-on-narrower-than-expected-q2-loss-analyst-blog-2014-08-04", "https://www.nasdaq.com/articles/why-the-earnings-streak-will-continue-for-seattle-genetics-sgen-tale-of-the-tape-2014-07", "https://www.nasdaq.com/articles/merck-kgaa-mersana-therapeutics-strike-a-deal-on-adcs-analyst-blog-2014-06-24", "https://www.nasdaq.com/articles/kite-pharma-drug-fares-well-in-non-hodgkins-lymphoma-study-analyst-blog-2014-08-26", "https://www.nasdaq.com/articles/seattle-genetics-investor-and-board-memeber-buys-9-million-stock-2014-06-06", "https://www.nasdaq.com/articles/seattle-genetics-larger-sp-500-component-patterson-companies-2014-05-23", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-july-19th-2014-05-20", "https://www.nasdaq.com/articles/first-week-sgen-december-20th-options-trading-2014-04-23", "https://www.nasdaq.com/articles/seattle-genetics-earns-milestone-payment-analyst-blog-2014-04-09", "https://www.nasdaq.com/articles/sgen-crosses-below-key-moving-average-level-2014-04-03", "https://www.nasdaq.com/articles/interesting-sgen-put-and-call-options-may-17th-2014-03-26", "https://www.nasdaq.com/articles/can-the-rally-in-seattle-genetics-sgen-shares-continue-tale-of-the-tape-2014-06-12", "https://www.nasdaq.com/articles/first-week-sgen-april-19th-options-trading-2014-02-26", "https://www.nasdaq.com/articles/earnings-reaction-history-seattle-genetics-inc-125-follow-through-indicator-45-sensitive", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-11-2014-dva-trip-wu-trmb-wsh-frt-acgl-pkg-fosl-sgen", "https://www.nasdaq.com/articles/japanese-approval-for-sgen-takedas-adcetris-analyst-blog-2014-01-20", "https://www.nasdaq.com/articles/seattle-gentics-abbvie-deal-expanded-analyst-blog-2014-01-09", "https://www.nasdaq.com/articles/stocks-insiders-buy-seattle-genetics-opko-health-and-ion-geophysical-2013-12-17", "https://www.nasdaq.com/articles/seattle-genetics-director-buys-16-million-shares-2013-12-17", "https://www.nasdaq.com/articles/seattle-genetics-presents-data-on-adcetris-analyst-blog-2014-02-28", "https://www.nasdaq.com/articles/bayer-eyeing-norwegian-oncology-firm-analyst-blog-2013-11-27", "https://www.nasdaq.com/articles/bayer-in-oncology-deals-analyst-blog-2013-10-15", "https://www.nasdaq.com/articles/vertex-progresses-with-kalydeco-analyst-blog-2013-10-07", "https://www.nasdaq.com/articles/intellipharmaceutics-reports-loss-analyst-blog-2013-10-07", "https://www.nasdaq.com/articles/bayer-inks-oncology-deal-analyst-blog-2013-08-06", "https://www.nasdaq.com/articles/bayer-seattle-genetics-join-forces-analyst-blog-2013-06-26", "https://www.nasdaq.com/articles/new-data-on-sgens-adcetris-analyst-blog-2013-06-25", "https://www.nasdaq.com/articles/insiders-buy-shares-dollar-general-and-seattle-genetics-rosetta-stone-sees-sale-2013-12-06", "https://www.nasdaq.com/articles/sgen-starts-adcetris-phase-i-ii-study-analyst-blog-2013-06-11", "https://www.nasdaq.com/articles/biotech-companies-see-insider-purchases-ceo-phillip-frost-increases-stake-opko-and-felix", "https://www.nasdaq.com/articles/sgens-adcetris-under-fda-review-analyst-blog-2013-05-16", "https://www.nasdaq.com/articles/narrower-than-expected-loss-at-seattle-genetics-analyst-blog-2013-05-08", "https://www.nasdaq.com/articles/pharmacyclics-inc-pcyc-todays-most-compelling-stock-buy-2013-05-07", "https://www.nasdaq.com/articles/polycyclics-inc-pcyc-todays-most-compelling-stock-pick-2013-04-26", "https://www.nasdaq.com/articles/astellas-ambrx-tie-up-on-adc-analyst-blog-2013-04-05", "https://www.nasdaq.com/articles/immunotherapy-four-companies-verge-cancer-treatment-breakthroughs-2013-06-17", "https://www.nasdaq.com/articles/sgen-seeks-adcetris-label-expansion-analyst-blog-2013-03-19", "https://www.nasdaq.com/articles/sgen-narrows-loss-sales-rise-analyst-blog-2013-02-13", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-12-2013-fti-rax-wu-frt-wsh-ddr-clf-acc-hcc-gwr-sgen", "https://www.nasdaq.com/articles/canada-approves-seattle-genetics-adcetris-analyst-blog-2013-02-04", "https://www.nasdaq.com/articles/data-from-sgen-on-cancer-candidate-analyst-blog-2013-01-29", "https://www.nasdaq.com/articles/sgen-takedas-adcetris-progresses-analyst-blog-2013-01-25", "https://www.nasdaq.com/articles/stock-could-be-perfect-dividend-decade-2013-01-08", "https://www.nasdaq.com/articles/takeda-files-adcetris-in-japan-analyst-blog-2013-03-27", "https://www.nasdaq.com/articles/weekly-cfo-sells-highlight-sbac-xoxo-mth-fico-sgen-oas-2012-09-03", "https://www.nasdaq.com/articles/seattle-genetics-draws-income-trade-2012-06-28", "https://www.nasdaq.com/articles/weekly-cfo-sells-highlight-swks-p-sgen-rt-2012-06-11", "https://www.nasdaq.com/articles/biotech-ideas-top-biotech-stocks-bullish-institutional-trends-2012-01-09", "https://www.nasdaq.com/articles/5-insider-stock-picks-predictive-analysts-expect-outperform-2011-11-16", "https://www.nasdaq.com/articles/bullish-outlook-10-stocks-near-highs-boosted-insider-buying-2011-11-06", "https://www.nasdaq.com/articles/welcome-new-bear-market-now-what-2011-10-06", "https://www.nasdaq.com/articles/weekly-cfo-sells-highlight-sgen-pfie-mar-esrx-liox-rgen-2012-09-10", "https://www.nasdaq.com/articles/weekly-cfo-sells-highlight-sbac-xoxo-mth-fico-sgen-oas-2012-09-03", "https://www.nasdaq.com/articles/after-fda-approval-will-seattle-genetics-meet-same-fate-dendreon-2011-08-23", "https://www.nasdaq.com/articles/stocks-mixed-investors-await-fed-meeting-minutes-commodities-higher-2011-07-12", "https://www.nasdaq.com/articles/mid-day-update-equities-mixed-while-commodities-sit-higher-investors-focus-fed-2011-07-12", "https://www.nasdaq.com/articles/narrowing-down-list-biotech-etfs-2-wed-recommend-2011-06-22", "https://www.nasdaq.com/articles/stocks-lower-investors-seek-clear-economic-indicators-weigh-fed-chairman-comments-2010-12", "https://www.nasdaq.com/articles/mid-day-update-stocks-modestly-lower-investors-seek-clear-direction-following-fed-chiefs", "https://www.nasdaq.com/articles/investing-101-short-squeeze-ideas-insider-buying-2011-09-23", "https://www.nasdaq.com/articles/13-biotechs-watch-hematology-conference-2009-11-30", "https://www.nasdaq.com/articles/amgen-celgene-and-novartis-fight-against-pancreatic-cancer-2010-10-26"], "Content": []}